






PROMOTING HIV TESTING BY MEN IN UGANDA: 












A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department 














Approved by:  
Harsha Thirumurthy 
Gabriel Chamie 
Juan Marcos Gonzalez 










































Elisabeth M. Schaffer 













Elisabeth M. Schaffer: Promoting HIV Testing by Men in Uganda: Aligning Preferences and 
Policy 
(Under the direction of Harsha Thirumurthy) 
 
 Background: Men in sub-Saharan Africa are less likely than women to test for HIV. The 
gap in male testing coverage leads to increased morbidity and mortality for HIV-positive men 
compared to HIV-positive women and to missed opportunities to prevent transmission. One 
approach that has demonstrated potential to increase male testing is community-based testing.  
Objective: The objective of this dissertation was to provide evidence-based guidance to 
optimize the delivery of community-based HIV testing to promote uptake by men in sub-Saharan 
Africa.  
Methods: I administered a discrete choice experiment (DCE) to a random sample of 203 
adult male residents of rural Uganda. The DCE elicited stated preferences for attributes of 
community-based testing that can be modified to promote testing. I used a random parameters 
logit model to estimate preferences and simulate uptake under alternative service delivery 
models. I estimated additional random utility models and conducted covariate analyses to 
investigate preference heterogeneity. I incorporated predictions of testing uptake into a decision 
analytic model to evaluate the cost-effectiveness of alternative service delivery models to 
increase HIV testing and diagnosis.  
Key Findings: Participants stated strong preferences for access to antiretroviral therapy 
(ART) at the time of testing. The predicted uptake of testing under alternative service delivery 
models increased 26-44 percentage points when immediate access to ART for HIV-positive 
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persons was provided. Incentives of US $0.85 also influenced participants’ choices and increased 
the predicted testing uptake 6-12 percentage points. It was unclear whether preference 
heterogeneity could be attributed to participants’ characteristics. The most cost-effective service 
delivery models to increase HIV testing were not necessarily most cost-effective at increasing 
diagnosis. Changes of only a few percentage points in the probability that men who access a 
given service delivery model would test positive greatly increased the likelihood that the service 
delivery model was cost-effective at increasing diagnosis. 
Conclusion: The stated preference methods used in this dissertation reveal opportunities 
to improve community-based HIV testing to encourage uptake by men. Further research is 
warranted to corroborate the external validity of stated preferences to predict revealed 
preferences and to determine how community-based service delivery models can effectively 
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This dissertation is organized in a non-traditional format. The first chapter provides an 
overview of the topic and presents the specific aims of the dissertation. Chapters 2, 3, and 4 are 
research papers for the three dissertation aims, intended to stand alone as publishable 
manuscripts and thus have redundancies with other chapters. Chapter 5 concludes with a 
summary of findings, implications for policy and practice, and plans for future research. 
Chapter 2 of this dissertation is under review for publication at the time of submitting this 
dissertation as part of my doctoral degree requirements to the faculty of the University of North 
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CHAPTER 1.  INTRODUCTION 
1.1. Overview and Specific Aims 
Increasing HIV awareness among HIV-positive persons is the first objective in a global 
strategy to end HIV/AIDS. To significantly reduce viral transmission by 2030, the Joint United 
Nations Program on HIV/AIDS (UNAIDS) has proposed the “90-90-90 targets” which urge 
countries to ensure that 90% of HIV-positive persons know they have HIV, 90% of persons 
diagnosed with HIV are receiving antiretroviral therapy (ART), and 90% of persons receiving 
ART are virally suppressed by 2020 (1). While considerable progress has been made to expand 
access to HIV testing, there are a number of important gaps in testing coverage including low 
coverage among men in sub-Saharan Africa. Men are less likely than women to have ever tested, 
to have tested recently, and to know when they are HIV-positive (2,3).  
HIV testing is an essential step to access treatment and care for HIV/AIDS, and low 
testing coverage among men in sub-Saharan Africa translates into missed opportunities to link 
HIV-positive men to services that are essential to promote and sustain their health. Consequences 
of the male testing gap include missed and late HIV diagnosis, delayed start of ART, and 
ultimately increased morbidity and mortality for HIV-positive men compared to HIV-positive 
women (4–9). HIV testing is also critical to prevent HIV transmission. Knowledge of one’s 
serostatus leads to safer sexual decision making. Individuals who learn that they are HIV-
positive following voluntary counseling and testing have fewer sexual partners and increased 
condom use than individuals who test HIV-negative (10,11). Additionally, ART has become 
fundamental to HIV prevention since the landmark HPTN 052 trial demonstrated that adherence 
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to ART reduces sexual transmission in serodiscordant couples by 96% (12). It is therefore 
critical that HIV-positive men know their status and enroll in treatment not only for their own 
health but to prevent HIV transmission to their sexual partners. Men who test HIV-negative also 
stand to benefit from learning their status. HIV testing provides an opportunity to link HIV-
negative men to voluntary medical male circumcision which reduces female-to-male HIV 
transmission by 50-60% (13–15) and to pre-exposure prophylaxis which reduces HIV acquisition 
from an HIV-positive partner by as much as 90% when taken daily with high adherence (16,17).   
One approach that has considerable potential to increase HIV testing by men and curtail 
consequences associated with the gap in male testing coverage is community-based HIV testing 
(18–20). Community-based testing takes HIV testing outside of health facilities to “reach people 
where they are”. Various community-based service delivery models have been implemented in 
sub-Saharan Africa including mobile, home, workplace, event, and self-testing programs (18,21). 
Compared to facility-based testing, community-based testing has achieved higher coverage 
among men (18), and it is likely that the convenience and accessibility of community-based HIV 
testing appeal to men and reduce barriers related to travel, costs, and stigma (22,23). Other 
advantages of community-based HIV testing include increased proportions of first-time testers 
and individuals who have high CD4 counts compared to facility-based testing (18,21). 
Additionally, community-based HIV testing achieves high enrollment in care and ART initiation 
when facilitated linkage support is provided (18).  
For these reasons, community-based HIV testing is a compelling approach to increase 
male testing coverage in sub-Saharan Africa, yet a number of important knowledge gaps must be 
addressed for decision makers to optimize the delivery of community-based HIV testing to 
promote uptake by men. The overall objective of this dissertation was to provide evidence-based 
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guidance for decision makers who seek to harness community-based HIV testing to promote 
testing by men in sub-Saharan Africa. I achieved this objective by pursuing three analytical aims. 
Specifically, my aims were to:  
Aim 1: Elicit men’s preferences for attributes of community-based HIV testing and 
predict uptake of HIV testing under alternative service delivery models;  
Aim 2: Describe heterogeneity in men’s preferences for attributes of community-based 
HIV testing;  
Aim 3: Evaluate the cost-effectiveness of alternative community-based service delivery  
models to increase HIV testing and HIV diagnosis among men. 
1.2. Methods 
My analytical approach involved a synthesis of methods from the fields of health 
economics and decision sciences. Each of these fields contributes unique strengths to decision 
making. Health economics provides a strong theoretical foundation and rigorous microeconomic 
modeling methods to investigate individual preferences and behavioral responses to health 
policies and interventions. Decision sciences, in turn, offers a range of mathematical modeling 
methods to incorporate what we know about diseases, people, and the impact of health policies 
and interventions to make population-level projections of effectiveness and cost-effectiveness 
under alternative scenarios. 
Given the need to promote HIV testing by men in sub-Saharan Africa, I first turned to the 
field of health economics and began my dissertation research with a stated preference study. 
Economists have long studied choices and, when choices are made in the real world, we can 
observe and analyze choices as revealed preferences. Stated preference research is similar to 
revealed preference research except that the choices individuals make are hypothetical (24). 
Although a potential pitfall of stated preference research is that hypothetical choices might not 
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reflect real world choices, evidence upholds the external validity of stated preferences to predict 
revealed preferences (25).  
The most well known type of stated preference research study and the type of study I 
conducted for my dissertation is a discrete choice experiment (DCE). A DCE is a survey that 
elicits individuals’ preferences for attributes of a product or service (26). Participants are 
presented with a series of hypothetical choices in which two or more product or service 
alternatives are compared. Each alternative is described by its attributes and participants are 
prompted to evaluate the attributes to choose their preferred alternatives (27,28). Responses are 
used to estimate preferences, which reveal the relative importance of the attributes for 
participants’ choices (29). A unique advantage of a DCE and the primary reason I employed a 
DCE for this dissertation is that preference estimates can also be used to predict uptake of 
alternatives (30–32). Uptake predictions provide a valuable link to the realm of mathematical 
modeling (33). By understanding how likely it is that individuals are to use a health product or, 
in this context of this dissertation, health service, we can model how engagement with health 
services translates into population health outcomes.  
This dissertation proceeds in two methodological phases. In Aims 1 and 2, I employ 
econometric modeling techniques to investigate men’s stated preferences and heterogeneity in 
men’s preferences for attributes of community-based service delivery models for HIV testing. I 
also use preference estimates to predict uptake of HIV testing under alternative service delivery 
models. In Aim 3, I incorporate uptake predictions into a mathematical model to predict the 
impact and cost-effectiveness of alternative community-based service delivery models to 
promote HIV testing and HIV diagnosis among men.  
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1.3. Research Setting 
The setting for my dissertation research was Uganda. An estimated 1.35 million people 
live with HIV in Uganda (34). As of 2017, 1.05 million (77%) have been diagnosed, and 950,000 
(68%) are receiving ART (34).  While over 90% of HIV-positive women and children have been 
diagnosed, only 61% of HIV-positive men have been diagnosed (34). Diagnosis of HIV among 
men is therefore critical to attain the first 90-90-90 target in Uganda.  
The HIV epidemic in Uganda is generalized and bears similarities to other HIV 
epidemics in Eastern and Southern Africa (35). Uganda began offering HIV testing in 1990 and 
the testing landscape has evolved dramatically since then (36). Voluntary counseling and testing 
is offered at health facilities, and a range of community-based service delivery models for HIV 
testing have been implemented including counselor-administered home-based testing, workplace 
testing, mobile testing, and HIV testing at community health campaigns (35). Since the end of 
2016, pilot demonstrations and randomized trials have been launched to investigate the use of 
oral fluid-based HIV self-tests to promote testing among target populations of fishermen, female 
sex workers, and male partners of women attending antenatal care (37–39). However, oral fluid-
based HIV self-tests are not yet widely available.  
1.4. Data 
The DCE was integrated into data collection for a large randomized trial 
(NCT02890459). The randomized trial enrolled adult (≥18 years) male residents from four 
neighboring parishes of Mbarara District, a rural district in southwestern Uganda, and 
investigated the comparative effectiveness of novel behavioral economic strategies to incentivize 
participants to test for HIV at a local community health campaign (40). Participants were 
identified for recruitment into the study by way of a household census. Eligible men who agreed 
and provided their informed consent to participate in the trial were administered an enrollment 
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questionnaire. The questionnaire asked participants about their socio-demographic 
characteristics, health, and history of HIV testing. The questionnaire also included the DCE, and 
the DCE was administered to a random subsample of trial participants. The questionnaire was 
administered before participants were randomized to different incentive interventions. Data 
collected by way of the enrollment questionnaire formed the principal data source for my 
dissertation. Aims 1 and 2 rely on these data. Aim 3 incorporates results from Aim 1 as input 
estimates for parameters of a mathematical model, along with additional parameter estimates that 
I collected from peer-reviewed literature and published sources.  
1.5. Significance and Innovation 
The research papers that here follow are significant because they provide timely evidence 
and strategic guidance for decision makers who seek to respond to a pressing challenge 
confronting the successful scale-up of HIV/AIDS services and attainment of the UNAIDS 90-90-
90 targets in sub-Saharan Africa. Others have realized and demonstrated how DCEs can be 
applied to generate uptake predictions that can be incorporated into mathematical models 
(33,41). I, however, am the first to apply these methods to determine how decision makers can 
promote HIV testing by men in sub-Saharan Africa. I apply a close awareness of the HIV testing 
landscape in sub-Saharan Africa and the policy frontier in Uganda to investigate service delivery 
models and interventions to promote male testing that have become policy relevant only recently. 
I thus deliver some of the first findings regarding the impact that such service delivery models 
and interventions are likely to have on uptake of HIV testing by men. Additionally, I advance the 
methods base for the use of DCEs to furnish estimates that can be incorporated into 
mathematical models by demonstrating how uptake predictions can be calibrated to match 







CHAPTER 2. PROMOTING HIV TESTING BY MEN: A DISCRETE CHOICE 
EXPERIMENT TO ELICIT PREFERENCES AND PREDICT UPTAKE UNDER 
ALTERNATIVE SERVICE DELIVERY MODELS IN UGANDA 
2.1. Introduction 
The Joint United Nations Program on HIV and AIDS (UNAIDS) has proposed a set of 
ambitious objectives known as the “90-90-90 targets” that countries should attain by 2020 in 
order to end the AIDS epidemic as a major global health threat by 2030. Increasing awareness of 
HIV status such that 90% of HIV-positive persons know their status constitutes the first target 
and sets the standard for progress toward the remaining two targets (1). While considerable 
progress has been made to expand access to HIV testing, there are a number of important gaps in 
testing coverage including low uptake by men in sub-Saharan Africa. Men are less likely than 
women to have ever tested and to have tested recently for HIV (2,3). Consequences of the testing 
disparity include missed or late diagnosis of HIV, delayed initiation of antiretroviral therapy 
(ART), and increased mortality for HIV-positive men (4–9). Low rates of male testing also 
constitute missed opportunities to prevent transmission as HIV testing provides not only an entry 
point for linking individuals to a health system for their own care but for providing treatment, 
counseling, and additional interventions for HIV prevention (12,42). 
Community-based HIV testing achieves higher coverage among men than standard 
facility-based testing and is a strategic approach to expand male testing (18,19). Various 
community-based service delivery models can be harnessed to deliver HIV testing. Mobile, 
home, and event-based service delivery models have been widely implemented in sub-Saharan 
Africa, and the World Health Organization (WHO) has recently called for the expansion of novel 
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service delivery models that use oral fluid-based HIV self-tests to promote testing, particularly 
among hard-to-reach and at-risk populations (43). Community-based service delivery models 
also provide flexible platforms to improve how HIV testing is delivered to encourage men to test 
for HIV. To the extent that certain attributes of how testing is delivered appeal to men and can be 
modified to motivate more men to test for HIV, such improvements can be considered 
interventions to increase male testing. For decision makers who seek to optimize the delivery of 
HIV testing to expand coverage among men, there is a vital need to identify attributes of HIV 
testing that men prefer and to prioritize service delivery models that increase uptake of HIV 
testing by men.  
A discrete choice experiment (DCE) is a useful survey tool for eliciting preferences for 
attributes of a health service and can also be used to predict uptake under alternative service 
delivery models (28,31). DCEs have grown increasingly popular in health economics, and a few 
studies have investigated preferences for HIV testing among diverse populations in sub-Saharan 
Africa (44–46). Yet, none have used a DCE to predict uptake of HIV testing under alternative 
service delivery models. Predictions are particularly useful when observed estimates of testing 
uptake are unavailable, as is the case for novel service delivery models and interventions to 
promote testing that have not yet been implemented. Moreover, predictions of testing uptake can 
be incorporated as parameters in mathematical models to assess the health outcomes and cost-
effectiveness of providing HIV testing to men under alternative service delivery models (33,41).  
To our knowledge, our study is the first to use a DCE to elicit preferences and predict 
uptake of HIV testing by men under alternative service delivery models in sub-Saharan Africa. 
We estimate preferences for community-based service delivery models that hold strong potential 
to appeal to men and for policy-relevant attributes of these service delivery models that represent 
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timely interventions that could be undertaken to increase male testing in sub-Saharan Africa. We 
then simulate uptake of HIV testing under different scenarios relevant to decision makers who 
seek to expand male testing coverage. Our findings are important as they reveal the comparative 
potential of promising service delivery models to promote male testing and indicate the impact 
that several interventions are likely to have on uptake of HIV testing by men in sub-Saharan 
Africa. 
2.2. Methods 
Study Setting and Population 
The DCE was conducted during the enrollment phase (April – June 2016) of a 
randomized trial investigating the comparative effectiveness of novel incentive strategies to 
encourage men to test for HIV at a local, multi-disease community health campaign 
(NCT02890459). The trial was conducted in Mbarara District, a rural region of southwestern 
Uganda where HIV prevalence among adult males is 7.0 - 8.0% (47).  
Prior to enrollment for the trial, we conducted a census of households in four neighboring 
parishes within Mbarara District. Male residents who were ≥18 years of age were eligible to 
participate in the trial if they had been living in the community for at least six months in the past 
year and were not planning to move away in the next three months. All eligible men present at 
the time of the census were invited to participate in the trial.1 Men who accepted to participate 
were administered an enrollment questionnaire. The DCE formed one section of the 
questionnaire.2  
                                                 
1If eligible men were not available when research assistants visited their homes, two additional attempts were made 
to reach the men.  
2Following administration of the enrollment questionnaire, participants were offered incentives to take an HIV test 
at a community health campaign that would be visiting their community in roughly 4-6 weeks. The incentives were 
material prizes, and participants were randomized to incentives that varied by type and cost. 
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The Discrete Choice Experiment  
Community-based service delivery models and attributes of HIV testing that can be 
leveraged to promote male testing were developed based on a literature review and expert 
confirmation. We first reviewed the literature to identify service delivery models that have been 
implemented or are under active consideration in sub-Saharan Africa and selected three based on 
their potential to increase HIV testing by men in Uganda: 1) HIV testing at a community health 
campaign; 2) counselor-administered home-based testing; and 3) HIV self-testing (HIVST) using 
an oral fluid-based test obtained at a local pharmacy. We then added attributes to the DCE to 
represent changes to how each service delivery model is implemented that could promote male 
testing. We included three binary attributes that indicated whether: 1) multi-disease testing; 2) 
immediate access to ART for HIV-positive persons; and 3) a financial incentive were available. 
These service delivery models and attributes are described below, and the levels used to describe 
the service delivery models and attributes to participants are presented in Table 1. 
Community-based service delivery models for HIV testing 
HIV testing at a community health campaign: Community health campaigns are a form of 
mobile testing that have achieved high population-level coverage of testing in several parts of 
sub-Saharan Africa (20,23,48,49).  Community health campaigns are held at convenient 
locations and typically offer HIV testing with other health services. Uptake of HIV testing by 
men at prior community health campaigns is high relative to facility-based testing (20).  
Counselor-administered home-based testing: Through home-based testing, a health 
counselor makes door-to-door visits to households in a community and offers to test household 
members for HIV. Home-based testing has been implemented in Uganda and found to be 
effective at reaching population groups with low rates of prior testing (36,50). Previous findings 
suggest men prefer home-based testing to facility-based testing (51,52).  
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HIVST using an oral fluid-based test obtained at a local pharmacy: Oral fluid-based HIV 
self-tests allow individuals to take their own sample, perform a simple test, and interpret the 
result on their own. HIVST has been shown to have high acceptability for diverse populations, 
including groups that are less likely to access facility-based testing (53–55). HIVST is not yet 
widely available in Uganda, and we included the distribution of self-tests at local pharmacies as a 
service delivery model that could be introduced.3  
Attributes of HIV testing 
Access to ART for HIV-positive persons: Ensuring immediate access to ART for 
individuals who test positive could be reassuring to men who are uncertain of their status. 
Further, many countries including Uganda have recently adopted WHO’s “Treat All” guideline 
recommendation that all individuals who are diagnosed with HIV should start ART, regardless of 
disease stage or CD4 count (42,56). Greater efforts are being made to ensure that ART is 
available at the time of HIV testing, and it is timely to assess the impact that providing 
immediate access to ART for HIV-positive persons could have on uptake of HIV testing by men. 
Availability of multi-disease testing: Providing testing for multiple diseases at the time of 
HIV testing could reduce barriers due to HIV-related stigma and appeal to men who perceive 
their risk of being HIV-positive to be low. Integration of testing services has recently been 
shown to be feasible in several countries, including Uganda, and is receiving growing attention 
                                                 
3We focused on distribution of self-tests at local pharmacies as pharmacies have considerable reach across Uganda. 
Moreover, a national campaign has been launched in neighboring Kenya to make self-tests available in pharmacies 
and there is therefore precedent for the distribution of self-tests at local pharmacies. Other distribution channels are, 
however, possible and under investigation elsewhere. 
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(20,57). We included the ability to test for tuberculosis, malaria, hypertension, and diabetes at 
the time of HIV testing as an attribute in the DCE.4  
Financial incentive for HIV testing: Offering incentives has been proposed as an 
intervention to increase male testing and could help offset financial or psychosocial costs that 
men associate with testing (58–61). A systematic review found that incentives are effective at 
increasing HIV testing for diverse populations, especially when testing is provided outside of 
health facilities (58). We included the provision of a fixed incentive of 3,000 Ugandan shillings 
(about US $0.85) for HIV testing as an attribute in the DCE.5  
Choice Sets and Experimental Design 
Choice sets were constructed to display two alternatives for HIV testing and an opt-out 
alternative so that participants could choose not to test if neither testing alternative appealed to 
them. Each testing alternative was defined by a specific service delivery model and set of 
attribute levels. In cases where pairing an attribute level with a specific service delivery model 
would result in combinations that policymakers would not consider implementing, we defined 
constraints such that the attribute and service delivery model levels were not paired.6  
In total, ten testing alternatives were possible and we generated an experimental design 
from the 45 unique pairwise combinations of alternatives that could be presented in choice sets. 
We selected a fraction of the total possible choice sets to ease participant burden. The natural 
preference ordering of the levels for the binary attributes increased the design efficiency and 
                                                 
4These diseases are endemic to the region and, in the case of non-communicable diseases, on the rise in sub-Saharan 
Africa. Screening for all of these diseases can be performed using rapid test technologies and is thus amenable to 
community-based delivery (see, for instance, Chamie et al, 2012). 
5This amount approximates the cost of transportation to a community-based venue.  
6 Four constraints total were included in the experimental design and are presented in Appendix A.  
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yielded several choice sets that allowed little information to be gained from the trade-offs made 
by a given choice; we excluded these choice sets. We evaluated the remaining choice sets and 
selected 10 to maximize the range of trade-offs that participants could make when choosing 
between testing alternatives. We blocked the experimental design into 2 versions of 5 choice sets 
and evaluated the design efficiency using Sawtooth Software (Orem, UT, USA). The steps taken 
to construct the experimental design are presented in Figure 1.  
Survey Administration  
Twenty-four enumerators were trained to enroll participants and administer a 
questionnaire using handheld tablets. The DCE section was programmed for random delivery to 
1 in 10 participants. Along with the handheld tablets, the enumerators were provided booklets 
that contained illustrations to describe the choice sets to participants. A sample choice set is 
presented in Figure 2. All questionnaire items were translated from English into Runyankole, the 
local language, and read aloud. During the first two weeks of enrollment, we field-tested a 
version of the DCE to assess participant understanding of the choice sets. We revised the 
wording of the levels and adjusted the formatting of the choice sets to enhance comprehension.  
2.3. ECONOMETRIC ANALYSIS 
Conceptual Framework and Random Parameters Logit Model Specification  
Random utility theory provides the conceptual framework for discrete choice analysis 
(62,63). According to random utility theory, the utility  an individual n derives from 
alternative i in choice set t consists of a deterministic component  that is a function of 
observed variables and an unobservable random component  such that:  
 =   +   =  
′ +   
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where   is a vector of observed variables that define alternative i and 
′ is a vector of marginal 
utility (i.e. preference) parameters associated with the variables. Different assumptions regarding 
the distribution of  lead to different random utility models (64).  
We employed a random parameters logit (RPL) model to estimate men’s preferences for 
HIV testing service delivery models and their attributes. The RPL model allows the parameters 
of observed variables to vary over individuals (64,65). The vector of parameter estimates 
′ for 
an individual n can be expressed as the sum of the population mean ′ and the individual 
deviation ′, which represents the individual’s preferences relative to the average preferences of 
the population (66): 
 =  
′ +  = ′ +  ′ +   
In this specification, ′ and ′ are estimated by the model, while ~,  and is correlated 
over alternatives and choices for individuals. The remaining term, , represents the 
unobserved portion of utility assumed to be independent and identically distributed extreme 
value. The RPL model is an appealing specification, as it allows for correlation across choices 
and heterogeneity in participant preferences.7 The RPL model also allows for flexible 
substitution patterns across choice alternatives. This flexibility is essential for generating 
accurate predictions of testing uptake.   
 Substituting variables for the levels associated with the alternatives participants viewed in 
the DCE yields the following empirical specification that we estimated:8 
                                                 
7For the choice context investigated here, it is likely that choices made by the same individual are correlated and that 
there is heterogeneity in preferences across our broad-based sample. 
8Model parameters were estimated using 500 Halton draws and standard errors clustered at the individual level. 
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 = 
 !""#$%&' ℎ)*+&ℎ ,*"-*%.$ +  
/01!")_*3)4 &)3&%$.
+ 
567018 3)+9_&)3&%$. + 
:;0<#+&%_4%3)*3) &)3&%$.
+  
=>08"")4%*&) ?@A +  
5B8$,)$&%C) + 
DE0F!#+4 $!& &)3&  
where  !""#$%&' ℎ)*+&ℎ ,*"-*%.$,  1!")_*3)4 &)3&%$. , 18 3)+9_&)3&%$. , 
<#+&%_4%3)*3) &)3&%$., 8"")4%*&) ?@A, and 8$,)$&%C) represent the levels that defined 
the testing alternatives and F!#+4 $!& &)3& is an alternative-specific constant that accounts for 
the fact that a participant could always choose to opt-out of HIV testing. We employed effects 
coding to ensure that the level parameters were not correlated with the constant for the opt-out 
alternative (67). We tested for interactions between the service delivery model and attribute 
levels. Additionally, we estimated a specification that allowed for correlation between 
coefficients.9 
Prediction and Calibration of HIV Testing Uptake 
Results from a RPL model are typically reported as mean coefficients, yet coefficients 
can also be simulated for each individual in the sample and we harnessed this capability to make 
predictions of testing uptake. We used the individual coefficients to calculate the utility that each 
individual associated with the testing alternatives presented in the DCE and the alternative to 
opt-out of HIV testing. We then applied a utility maximization rule that an individual would test 
for HIV under a given service delivery model if his utility for that alternative exceeded his utility 
for all other alternatives in a given choice scenario. Finally, we compared our predictions to 
observed estimates of testing uptake reported in peer-reviewed literature and calibrated our 
predictions to achieve concordance with reference values for service delivery models that have 
                                                 
9The inclusion of constraints in the experimental design made it possible that coefficients were correlated. We 
estimated a RPL model that allows coefficients to be correlated to account for this possibility.  
16 
been implemented in the study context.10 All analyses were conducted using Stata 14.1 
(StataCorp, College Station, TX, USA). 
2.4. Results 
Sample Characteristics 
In total, 203 men (88% of those who were eligible to participate in the randomized trial 
and who were randomly selected to receive the DCE) participated in the DCE. Nine participants 
self-reported an HIV-positive status at enrollment and were excluded from analysis. 
Characteristics of participants who comprised the analytical sample are presented in Table 2. 
Most participants had a primary education or less (70%), were employed in agriculture or 
manual labor (74%), and were married (63%). One-third (34%) were less than 30 years of age 
and over half (53%) reported that they tested for HIV in the past 12 months. Eighteen percent of 
participants perceived their risk of HIV to be moderate or high, and 23% had two or more sexual 
partners in the past 12 months.  
Estimated Preferences 
Table 3 presents results from the RPL model. The results were largely similar across 
specifications. The large negative coefficient for the alternative-specific constant for the opt-out 
alternative reveals that, on average, participants preferred to test for HIV using the testing 
alternatives presented in the DCE rather than to opt-out of HIV testing. Counselor-administered 
home-based testing and HIV testing at a community health campaign were generally preferred 
over obtaining an oral fluid-based self-test at a local pharmacy. Ensuring immediate access to 
ART for HIV-positive persons and the provision of a US $0.85 incentive for HIV testing 
                                                 
10We followed a calibration procedure described by Kenneth Train in Discrete Choice Methods with Simulation 
(2009). Further information regarding the calibration procedure and the reference values used to achieve 
concordance between predicted and observed estimates of testing uptake is presented in Appendix B.  
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increased the probability that an alternative was chosen. The availability of multi-disease testing 
was found to increase the probability that an alternative was chosen only in the specification that 
included interaction terms. Likelihood ratio tests revealed that the specifications with interaction 
terms and correlated coefficients considerably improved model fit. We selected the model that 
allowed for correlation between coefficients as our final specification as it best captures the 
uncertainty around model parameters. We discuss the remainder of our results with respect to 
this specification. 
To facilitate interpretation of the relative importance of the attributes (including the 
service delivery model) on participants’ choices, we plotted the coefficients in Figure 3. 
Immediate access to ART for HIV-positive persons was the strongest driver of choices, followed 
by the service delivery model and the provision of a US $0.85 incentive. The coefficient plots for 
the availability of multi-disease testing suggest a positive effect on choices, yet the overlapping 
standard error bars for the coefficients reveal that this effect was not significant (p = 0.10).  
Predicted Uptake of HIV Testing 
Figure 4 displays the predicted uptake of HIV testing by adult men when a single 
community-based service delivery model is implemented in rural Uganda.11 HIVST using an oral 
fluid-based test obtained at a local pharmacy yielded the smallest yet still considerable predicted 
uptake of 32% of adult men. Counselor-administered home-based testing and HIV testing at a 
community health campaign garnered 47% and 64% predicted uptake by adult men, respectively. 
The predicted uptake of HIV testing under the different service delivery models was augmented 
                                                 
11Predictions of testing uptake have been calibrated to match uptake by 64% of adult men of HIV testing at a 
community health campaign as reported by Chamie et al., 2016. The community health campaign was a base case 
service delivery model where multi-disease testing was provided but incentives and immediate access to ART for 
HIV-positive persons were not (68). Further details are provided in Appendix B.   
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by modifying attributes of how testing is delivered. Offering incentives of US $0.85 increased 
the predicted uptake by 6-12 percentage points. Providing immediate access to ART for HIV-
positive persons increased the predicted uptake by 26-44 percentage points. Providing multi-
disease testing increased the predicted uptake by 28 percentage points, an effect that was specific 
to uptake of counselor-administered home-based testing.12  
Figure 5 displays the predicted uptake of HIV testing by adult men when two 
community-based service delivery models for HIV are implemented concurrently.13 The 
cumulative predicted uptake of HIV testing under different combinations of two service delivery 
models ranged from 84-92%. The highest predicted uptake (91-92%) was achieved when one of 
the service delivery models provided immediate access to ART for HIV-positive persons. 
2.5. Discussion 
This DCE found that men in Uganda state that they are willing to use community-based 
service delivery models to test for HIV. We predicted that implementing community-based 
service delivery models for HIV testing singly and in tandem can result in uptake of HIV testing 
by over 90% of adult men. These findings are important in light of the strong interest and priority 
given to identifying low-cost HIV testing service delivery models that can help countries attain 
the UNAIDS 90-90-90 targets to significantly reduce viral transmission (34).  
Of the service delivery models investigated, HIV testing at a community health campaign 
and counselor-administered home-based testing demonstrated the greatest potential to appeal 
                                                 
12The impact of providing multi-disease testing on testing uptake is only estimated for the home-based testing 
service delivery model due to constraints included in the experimental design.     
13To attain the ambitious 90-90-90 targets, decision makers might consider implementing not just a single 
community-based service delivery model but two service delivery models in tandem. The predicted uptake of HIV 
testing under two community-based service delivery models has been calibrated to match uptake by 86% of adult 
men who tested for HIV at either a community health campaign or by way of counselor-administered home-based 
testing as reported in Chamie et al., 2016. Further details are provided in Appendix B.  
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broadly to men residing in rural Uganda. Both of these service delivery models have been 
implemented and enhanced uptake of HIV testing in Uganda (36,50). It is therefore not 
surprising that men are willing to use these service delivery models. It is, however, unexpected 
that men preferred the previously implemented service delivery models for HIV testing over 
HIVST given that high levels of acceptability with HIVST have been reported elsewhere 
(53,54,69–71) . That HIVST was the least preferred service delivery model could suggest that 
HIVST holds limited appeal for men residing in rural Uganda. It is also possible that a lack of 
familiarity with HIVST diminished appreciation for it. During the DCE, participants were 
provided basic information regarding the service delivery models, and it is likely that additional 
education and marketing is needed to increase demand for HIVST.  
We also found that attributes of how HIV testing is delivered are important and influence 
men’s choices. Above all, men preferred that ART be immediately available for HIV-positive 
persons at the time of HIV testing. Many community-based service delivery models for HIV 
testing do not currently offer ART. Rather, the standard of care is to link individuals who test 
positive to a health facility to undergo confirmatory testing and begin ART. That men prioritized 
immediate access to ART for HIV-positive persons so strongly is illuminating and indicates one 
way that community-based testing can be improved to enhance uptake of HIV testing. Providing 
confirmatory testing and a starter antiretroviral regimen for individuals who test positive at 
community-based venues could be an effective intervention to increase male testing. This finding 
is momentous given that many countries have recently adopted WHO’s “Treat All” guideline 
recommendation (42). Recent studies have found that ART initiation on the same day of HIV 
diagnosis is feasible and improves uptake of ART in clinical settings (72,73). Our results indicate 
that providing immediate access to ART through community-based service delivery models for 
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HIV testing is likely to have another important benefit to increase uptake of HIV testing. Further 
research is needed to investigate the feasibility of providing ART through community-based 
service delivery models for HIV testing and to identify effective strategies for linking HIV-
positive persons to long-term treatment and care. 
The provision of a US $0.85 incentive also influenced men’s choices. Recent experiments 
have demonstrated that incentives are effective at increasing HIV testing for adolescents and 
families in sub-Saharan Africa (74,75), and our results add evidence that financial incentives are 
likely to be an effective intervention to increase HIV testing for men. Although the predicted 
increase in uptake associated with offering an incentive for HIV testing in the DCE was not as 
large as the predicted change associated with providing immediate access to ART, the cost of the 
incentive was only US $0.85. It is therefore possible that a relatively small payment is a cost-
effective intervention to promote male testing, and further research is needed to investigate the 
elasticity of testing behaviors in response to changes in the level of payment.  
We acknowledge several limitations of the study. The DCE elicited men’s preferences for 
attributes of HIV testing that are highly relevant from a policy perspective, yet we did not 
conduct formative research prior to the DCE to establish attributes that are important to the study 
population. It is possible that additional attributes influence men’s decisions to test for HIV. Any 
attributes that were not defined in the DCE were assumed to be constant across testing 
alternatives or indicated by the service delivery model. We acknowledge our results could have 
been affected if participants mistakenly associated influential attributes that were not defined in 
the DCE with particular service delivery models. Second, we employed an experimental design 
that included constraints between service delivery model and attribute level combinations, and it 
is possible that we did not fully isolate the effects of highly constrained attributes. The 
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availability of multi-disease testing, in particular, was highly constrained and was not found to 
significantly influence men’s choices on average, yet our predictions of testing uptake suggest 
that offering multi-disease testing can increase testing under counselor-administered home-based 
testing. We therefore recommend that the results regarding multi-disease testing be interpreted in 
context. Third, our exclusion criteria and sampling strategy might have resulted in 
underrepresentation of residents who were highly mobile or absent from the community for 
extended duration, and the generalizability of our results could be limited for certain 
subpopulations. Lastly, we investigated preferences among a broad sample to respond to the 
challenge of low population-level uptake of HIV testing by men, yet another approach to ensure 
that 90% of men who are living with HIV know their HIV status is to target subgroups of men 
who are at high risk of acquiring HIV. Both approaches are important for the health of men and 
for HIV prevention. We do not distinguish the preferences of high-risk subgroups in this study 
yet encourage further research to do so. 
Despite its limitations, this study provides useful guidance for decision makers who seek 
to expand HIV testing coverage among men in sub-Saharan Africa. Decision makers should 
consider providing immediate access to ART for HIV-positive persons and offering financial 
incentives to increase uptake of community-based HIV testing by men. Our work compels 
further investigation of the costs associated with providing ART and financial incentives through 
community-based service delivery models for HIV testing in order to evaluate the cost-
effectiveness of these interventions to increase male testing. Additionally, our work demonstrates 
the importance of sensitizing communities to the use and benefits of HIVST prior to its 
introduction. Finally, further research to understand individual, interpersonal or societal 
characteristics that influence men’s decisions to test for HIV is warranted. Such findings could 
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help target the delivery of HIV testing to subgroups of men and address other barriers that men 
face when accessing HIV testing. Collectively, these actions will improve the responsiveness of 
testing services to promote male testing and aid progress toward the 90-90-90 targets. 
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Table 1. Attributes and Levels Included in the DCE 
Attribute  Levels 
Service delivery model - You attend a community health event in your village 
- A health counselor comes to your home and offers to test you for HIV 
- You pick up a self-test kit at a nearby pharmacy 
Availability of multi-
disease testing services 
- You can test for tuberculosis, malaria, pressure and diabetes when you 
test for HIV a  
- Only HIV testing is available 
Access to ART for HIV-
positive persons 
- Medications to treat HIV are immediately available 
- Medications to treat HIV are not immediately available 
Provision of an incentive 
for HIV testing 
- You receive 3,000 Shillings when you test for HIV 
- You do not receive compensation 







Table 2. Participant Characteristics 
 
N (%) 
Total participants a 194 
Age (years) 
 
18-29 65 (34) 
30-49 82 (42) 
50+ 47 (24) 
Highest level of education attained 
Primary or less 136 (70) 
Secondary 44 (23) 
Beyond secondary 14 (7) 
Occupation  
Agriculture/farming 100 (52) 
Manual labor 42 (22) 
Professional or business 33 (17) 
Other 19 (10) 
Marital status 
Married or cohabitating 122 (63) 
Never married  51 (26) 
Separated/divorced/widowed 21 (11) 
Tested for HIV in the past 12 months  
No 91 (47) 
Yes 103 (53) 
Self-perceived risk of having HIV 
No risk 66 (34) 
Low risk 88 (45) 
Moderate to high risk 35 (18) 
Unknown risk 5 (3) 
Number of sexual partners in the past 12 months  
No partners 32 (17) 
1 partner 117 (61) 
2 or more partners 44 (23) 
a Excludes 9 participants who self-reported a seropositive status at 
enrollment. 
 
Table 3. Estimation of Men’s Preferences for Service Delivery Models and Attributes of HIV Testing under Random Parameter Logit 
Model Specifications with and without Interaction Terms and Correlation between Model Coefficients 
  Model 1  Model 2  Model 3 
 
 
Base RPL specification 
 RPL with interaction 
terms 
 RPL with correlated 
coefficients 
Variables  β SE  β SE  β SE 
HIV testing at a community health 
campaign (CHC) 
 
0.64** (0.25)  0.13 (0.38)  0.22 (0.32) 
Home-based testing (HBT)  0.21 (0.13)  0.57* (0.22)  0.53* (0.21) 
HIV self-testing (HIVST)  -0.86*** (0.20)  -0.70** (0.25)  -0.75** (0.25) 
Multi-disease testing is available  0.17 (0.20)  0.63* (0.30)  0.55 (0.34) 
ART is immediately available 
(ART) 
 
1.09*** (0.18)  1.51*** (0.33)  1.38*** (0.32) 
An incentive of US $0.85 is 
provided  
 
0.25* (0.11)  0.39* (0.18)  0.33* (0.15) 
Would not test for HIV   -7.46*** (1.36)  -9.59*** (2.62)  -8.60*** (1.72) 
Interaction terms          
CHC*ART     0.58 (0.31)    
HBT*ART     -0.58 (0.31)    
CHC*Incentive     0.04 (0.35)    
HIVST*Incentive     -0.04 (0.35)    
Goodness of fit           
Log-likelihood  -535.02   -523.96   -518.97  
AIC / BIC  1094.05 / 1165.76  1079.92 / 1175.53  1091.94 / 1253.29 
Likelihood ratio test     Model 2 vs. Model 1  Model 3 vs. Model 1 
Likelihood ratio test statistic     22.13  32.11 
Likelihood ratio p-value     0.0002   0.0062  
Observations  2,910   2,910   2,910  
Results are reported as mean coefficients with robust standard errors in parentheses; *** p<0.001, ** p<0.01, * p<0.05. RPL, random 





Figure 1. Construction of the Experimental Design 
Defined constraints between attribute 
levels and service delivery models 
(n = 4) 
Identified distinct testing alternatives that 
could be combined in choice sets 
(n = 10) 
Choice sets possible with 
design constraints 
(n = 45) 
Choice sets excluded due to 
dominant preference orderings 
(n = 11) 
Choice sets evaluated for 
trade-offs 
(n = 34) 
Choice sets excluded to 
reduce respondent burden 
(n = 24) 
Choice sets included in 
experimental design 
(n = 10) 
Choice sets randomized to 
survey version 1 
(n = 5) 
Choice sets randomized to 
survey version 2 
(n = 5) 
 





Figure 3. Relative Importance of Attributes on Men’s Choices 
  
Mean preference estimates have been rescaled by a factor of ten. The vertical distance between 
coefficients for the levels of a given attribute indicates the relative importance of the attribute on 
participants’ choices. ART, antiretroviral therapy 
 
Figure 4. Predicted Uptake of HIV Testing under a Single Community-Based Service Delivery Model 
 





Figure 5. Predicted Uptake of HIV Testing when Two Community-Based Service Delivery 
Models are Implemented in Tandem 
 
For the sake of comparison, one service delivery models has been set to a base case community 
health campaign when the alternative service delivery model is either HIVST or home-based 
testing. The comparison service delivery model is switched to a base case version of counselor-
administered home-based testing when the alternative service delivery model is HIV testing at a 
community health campaign. MDT, multi-disease testing; ART, immediate access to 









CHAPTER 3.  UNDERSTANDING PREFERENCE HETEROGENEITY TO INCREASE 
HIV TESTING BY MEN IN UGANDA 
3.1. Introduction 
Increasing HIV awareness so that 90% of HIV-positive persons know that they have HIV 
is the first objective in a global strategy to significantly reduce viral transmission and bring the 
HIV/AIDS epidemic to an end (1). In order to attain this ambitious target, it is important for HIV 
testing to be widely accessible and acceptable to diverse populations. Although remarkable 
progress has been made to expand access to HIV testing, key gaps in testing coverage remain. A 
strong body of evidence indicates that across sub-Saharan Africa, men are less likely than 
women to test for HIV and be aware of their status when they are HIV-positive (2,3,76). Various 
hypotheses point to structural, cultural, and social factors that underlie the male testing gap 
(22,77–79). While these factors are complex, interrelated, and challenging to address, what is 
evident is that standard facility-based testing holds limited appeal for men. One way to try to 
increase uptake of HIV testing by men is to elicit men’s preferences for HIV testing and identify 
ways that testing services can be improved to encourage more men to learn their HIV status.    
A discrete choice experiment (DCE) is a useful survey tool for eliciting user’s 
preferences for health services (26). A DCE consists of a series of hypothetical choice scenarios 
in which two or more health services are described by their attributes, and participants are asked 
to evaluate the attributes and choose the service they prefer to use in each scenario (27,30). The 
primary outputs from a DCE are quantitative estimates of participants’ preferences for attributes 
of the health service (29). These estimates can be compared to assess the relative importance of 
the attributes for participants’ choices. Results from a DCE are typically reported as mean 
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preference estimates for the sample, and DCEs often yield useful findings regarding population 
preferences for attributes of health services that can be modified to increase health service 
utilization. Population preferences are policymakers’ primary interest in many cases; however, 
mean preference estimates alone do not reveal the heterogeneity in preferences that can be a rich 
source of information regarding the distribution of preferences within a diverse sample and the 
variation in preferences within a population at large. Fortunately, rigorous methods can be 
applied to analyze and describe preference heterogeneity using data collected from a DCE. 
This paper presents the results of an in-depth investigation of heterogeneity in men’s 
preferences for attributes of community-based HIV testing. Community-based delivery of HIV 
testing in which HIV testing is provided outside of health facilities has achieved higher uptake 
by men, compared to facility-based testing alone, and is a strategic approach to expand male 
testing (18,22).  We previously reported the findings of a DCE regarding preferences and the 
predicted uptake of HIV testing under community-based service delivery models for a broad 
sample of men who are representative of the adult male population of rural Uganda (80). We 
extended our investigation for this paper to analyze preference heterogeneity, as it is likely that 
not all men have the same preferences for HIV testing and it is beneficial to determine to what 
extent and how preferences vary in order to enhance testing uptake. Moreover, HIV testing is 
particularly important for certain subgroups of men, such as those who are at heightened risk of 
acquiring HIV and those who have not tested recently, and we sought to discover ways that HIV 
testing can be enhanced to increase uptake by these subgroups.  
DCEs have grown increasingly popular in health economics, and two studies have 
reported findings regarding heterogeneity in men’s preferences for attributes of HIV testing in 
sub-Saharan Africa (44,45). Ostermann and colleagues (2014) investigated preferences among 
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adults in urban Tanzania and found that the most important attribute to male participants was 
distance to the testing site, followed by the method of sample collection, and the degree of 
confidentiality.1 The authors estimated preferences using a random parameters logit model that 
allows preferences to vary across individuals and found significant heterogeneity in preferences. 
Subgroup analyses revealed that compared to men who had previously tested, men who had 
never tested for HIV were more likely to prefer oral HIV tests and less likely to prefer 
venipuncture. Compared to men who had tested in the past year, men who had not tested recently 
were more likely to prefer venipuncture, weekend testing, and that no one know they tested for 
HIV. Ostermann and colleagues (2015) also discovered significant differences in the preferences 
of a high-risk population of male mountain porters in a subsequent study. Mountain porters were 
less averse to traveling longer distances to testing sites and were more likely to prefer having 
access to treatment at the testing site than their urban counterparts. These findings suggest that 
men’s preferences for HIV testing vary and beckon further analyses of preference heterogeneity 
in population-based DCEs.  
Our work builds on these previous studies to investigate heterogeneity in preferences for 
attributes of HIV testing among a representative sample of adult men from rural Uganda. We 
advance the literature by employing advanced modeling methods and present a systematic 
approach for investigating unobserved and observed preference heterogeneity. Similar to 
Ostermann and colleagues, we employ a random parameters logit model. We also estimate a 
standard conditional logit model and a latent class logit model. Each model specification makes 
different assumptions about preference heterogeneity, and we compare the results to demonstrate 
                                                 
1Collectively, men preferred shorter distances to the testing site (yet preferred testing 1 km away from their homes 
over testing at home), finger prick tests over venipuncture or an oral swab, and that their spouses know that they 
tested for HIV over no one or many people knowing that they tested. 
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the importance of accounting for unobserved heterogeneity in men’s preferences. Additionally, 
we conduct covariate analyses to investigate preference heterogeneity that can be attributed to 
observed characteristics of participants. We apply methods appropriate to each model 
specification and provide a framework for investigating ways to tailor HIV testing to promote 
uptake by subgroups.  
3.2. Methods 
 The DCE was conducted during the enrollment phase of a randomized trial investigating 
the comparative effectiveness of novel incentive strategies to encourage men to test for HIV at a 
local, multi-disease community health campaign (NCT02890459). Adult male residents were 
invited to participate in the randomized trial during a census of households in four neighboring 
parishes within Mbarara District, a rural District in southwestern Uganda where the adult male 
HIV prevalence is 7 – 8% (47). Male residents who were ≥18 years of age were eligible to 
participate in the trial if they had been living in the community for at least six months in the past 
year and were not planning to move away in the next three months (40). All eligible men present 
at the time of the census were invited to participate in the trial. Those who agreed and provided 
their informed consent were administered an enrollment questionnaire. The DCE formed one 
section of the questionnaire and was administered to a random subsample of 203 participants. 
Following administration of the enrollment questionnaire, participants were offered incentives to 
take an HIV test at a community health campaign that would be visiting their community in 
roughly 4-6 weeks. The incentives were material prizes, and participants were randomized to 
incentives that varied by type and cost.  
 Each man who participated in the DCE evaluated 5 choice sets. The choice sets displayed 
2 alternatives for HIV testing and an opt-out alternative so that participants could choose not to 
test if neither testing alternative appealed to them. Each testing alternative was characterized by 
35 
four attributes (Table 4), the first of which was a three-level attribute indicating the community-
based service delivery model for HIV testing. The service delivery models included in the DCE 
were: 1) HIV testing at a community health campaign; 2) counselor-administered home-based 
testing; and 3) HIV self-testing (HIVST) using an oral fluid-based test obtained at a local 
pharmacy. The additional three attributes each had two levels that indicated whether or not 
multi-disease testing, immediate access to antiretroviral therapy (ART), and a financial incentive 
of 3,000 Ugandan shillings (approximately US $0.85) were available at the time of HIV testing. 
These binary attributes represent ways that policymakers could seek to improve the delivery of 
community-based HIV testing to enhance uptake by men. The administration of the DCE has 
been previously described (80), so we limit our description of statistical methods to those used to 
investigate preference heterogeneity.  
Discrete Choice Modeling of Preference Heterogeneity 
A number of random utility models can be applied to analyze data from a discrete choice 
experiment, all of which begin with the common framework of random utility theory (62,63). 
According to random utility theory, the utility  an individual n derives from alternative i in 
choice set t consists of a deterministic component  that is a function of observed variables 
and an unobservable random component ε such that:  
H =  I +   =  J
KL +     (1) 
where   is a vector of attribute levels that define alternative i and 

K
 is a vector of marginal 
utility (i.e. preference) parameters associated with the attribute levels. We assume that individual 
n makes choices to maximize his utility such that he will choose alternative i over another 
alternative j in choice set t if and only if   >  N, ∀ P ≠ %.  
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As researchers, we observe attributes of the alternatives and specify  accordingly. For 
the current application, specifying variables for the attribute levels associated with the 
alternatives participants viewed in the DCE yielded the following utility function: 
 = 
 !""#$%&' ℎ)*+&ℎ ,*"-*%.$ +  
/01!")_*3)4 &)3&%$.
+ 
567018 3)+9_&)3&%$. + 
:;0<#+&%_4%3)*3) &)3&%$.
+  
=>08"")4%*&) ?@A +  
5B8$,)$&%C) + 
DE0F!#+4 $!& &)3&
+   
where  !""#$%&' ℎ)*+&ℎ ,*"-*%.$,  1!")_*3)4 &)3&%$. , 18 3)+9_&)3&%$. , 
<#+&%_4%3)*3) &)3&%$., 8"")4%*&) ?@A, and 8$,)$&%C) represent the attribute levels that 
defined the testing alternatives and F!#+4 $!& &)3& is an alternative-specific constant that 
accounts for the fact that a participant could always choose to opt-out of HIV testing. We do not 
observe ε, however, and therefore have to make an assumption about its distribution (64). 
Different assumptions about the distribution of ε give rise to different random utility models. 
Historically, McFaddon’s conditional logit (CL) model has been a popular model 
specification (81). The CL model assumes that the random variables that compose ε are 
independent and identically distributed with an extreme value distribution. Conditional on 
knowing 










    (2) 
The probability that individual n makes a particular sequence of choices, conditional on knowing 

 is a product of choice probabilities: 
_
 =  ∏ R,

0
ab    (3) 
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This choice probability is a closed-form expression that can be evaluated through maximum 
likelihood estimation, and an advantage of the CL model is its ease of computation. Yet, an 
important limitation of the CL model is that it assumes that preferences are the same across 
individuals (29,82). Another limitation of the CL model is that it assumes choices are 
independent (64,82). In many cases, it is likely that preferences vary across individuals and, in 
the context of a DCE, it is highly likely that choices made by the same individual are correlated.  
Two models that relax the assumptions of the CL model are the random parameters logit 
(RPL) and latent class logit (LCL) models (83,84). The probability that individual n makes a 
particular sequence of choices for both the RPL and LCL models is given by (65,66,82):  
cd =  e _
9
|d4
   (4) 
This choice probability is the unconditional probability of a particular sequence of choices and is 
the conditional probability integrated over the distribution of 
. Preferences vary with a density 
9
|d where d are the parameters of the distribution.2 The distribution of 
 is assumed to be 
continuous in a RPL model, whereas the LCL model assumes the distribution of 
 is discrete and 
takes on a finite number of values.  
The continuous distribution of 
 in the case of the RPL leads to a log-likelihood function 
that cannot be solved analytically but can be approximated through maximum likelihood 
simulation, provided that the distribution of 
 is specified in advance. The log-likelihood 
function of LCL model, on the other hand, can be solved using maximum likelihood estimation, 
provided that the number of discrete preference classes is specified in advance.  
                                                 
2It can be seen that if it is assumed that all individuals have the same preferences, the distribution is discrete and 
takes a single value. In this case, equation 4 collapses to equation 3.  
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To investigate whether the more advanced RPL and LCL model specifications that 
accommodate preference heterogeneity are preferred specifications relative to the standard CL 
model specification, we first estimated each model. We simulated the RPL model assuming a 
normal distribution for 
. We estimated multiple LCL models that allowed for 1 – 7 latent 
classes and compared their estimation properties and goodness-of-fit measures to select a 3-class 
model as the preferred LCL specification. 
We then examined the results of the RPL and LCL models for signs of preference 
heterogeneity and compared goodness-of-fit measures across the CL, RPL, and LCL model 
specifications to evaluate the performance of each specification to estimate men’s preferences for 
attributes of HIV testing. We examined Akaike and Bayesian information criteria (AIC/BIC) and 
log-likelihood values. Additionally, we performed likelihood ratio (LR) tests to determine 
whether the RPL and LCL model specifications significantly improved model fit relative to the 
CL logit model. We also performed a LR test to compare the LCL to the RPL model 
specification.  
Covariate Analyses 
The RPL and LCL models account for and yield valuable information about preference 
heterogeneity, yet the heterogeneity is unobserved in that it is not attributable to individual 
characteristics of participants. Decision makers who seek to promote HIV testing among priority 
subgroups of high-risk and hard-to-reach men are likely interested to know whether the 
preferences of these subgroups are distinct from the preferences of men-at-large. The ability to 
detect heterogeneity according to characteristics of participants is therefore also valuable. Before 
the DCE was administered, participants responded to questionnaire items that assessed their 
demographic characteristics, history of HIV testing, and health and sexual behavior; we used 
these data to conduct covariate analyses to investigate whether heterogeneity in men’s 
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preferences for attributes of HIV testing was associated with observed characteristics of 
participants.  
Estimating preferences using the CL and RPL models, we conducted subgroup analyses 
in which we interacted each attribute level variable and the constant for the alternative to opt-out 
of HIV testing with a dichotomous variable that defined participant subgroups. The new 
interaction variables were included in the model specification to evaluate the difference in the 
marginal utility of the attribute levels and the alternative-specific constant between those in and 
out of the subgroups of interest. We defined subgroups (Table 5) according to history of recent 
HIV testing (whether a participant had tested for HIV in the past 12 months or not), self-
perceived risk of HIV (whether a participant perceived himself to have no or low risk as opposed 
to moderate to high risk of acquiring HIV), and self-reported sexual behavior (whether a 
participant had 0-1 nonpaid sexual partners versus 2 or more sexual partners or at least 1 paid 
sexual partner in the past 12 months). Additionally, we conducted subgroup analyses for select 
demographic characteristics, including age (whether a participant was aged less than 30 years 
versus 30 years or older), marital status (whether a participant was never married versus married, 
separated, widowed, or divorced), and highest educational level attained (whether a participant 
had primary education or less versus more than primary education).   
As latent classes are themselves subgroups of the population, we did not conduct 
subgroup analyses for preferences estimated using the LCL model specification. Instead, we 
investigated whether the previously mentioned testing history, risk, and demographic 
characteristics of participants were predictors of latent class membership. We estimated 
unadjusted and adjusted odds ratios using a multinomial logistic regression model in which the 
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three latent classes were treated as a categorical outcome. All analyses were conducted using 
Stata 14.1 (StataCorp, College Station, TX, USA). 
3.3. Results 
Preference Estimation and Heterogeneity 
Preferences estimated using the CL, RPL, and LCL model specifications are presented in 
Tables 6-8. In the case of the CL model specification, mean coefficients for the sample along 
with their associated standard errors alone are reported. The RPL model specification yielded 
mean coefficients for the sample along with standard deviations that reveal whether there was 
significant heterogeneity in participants’ individual preferences for the attribute levels included 
in the DCE. The LCL model specification produced mean coefficients for three latent classes of 
participants that were identified as having similar preferences. The latent classes were estimated 
to represent 57%, 30%, and 13% of participants. Despite differences in the presentation of 
results, two findings were consistent across model specifications. The relatively large negative 
value of the coefficient for the alternative to opt-out of HIV testing across model specifications 
reveals that, on average, participants assigned greater utility to the average testing alternative 
presented in the DCE than to the alternative to opt-out of HIV testing. Additionally, the 
consistently large, positive coefficient for the provision of immediate access to ART for HIV-
positive persons at the time of HIV testing for all but a single latent class for whom this attribute 
was not significant suggests that this attribute was an important determinant of participants’ 
choices. 
Goodness-of-fit measures comparing the three random utility model specifications are 
provided in Table 9. The AIC and BIC values were smaller and the log-likelihood values were 
closer to zero for the RPL and LCL model specifications relative to the CL model specification. 
Likelihood ratio tests also indicated that the RPL (LR test statistic = 1130.91, p < 0.01) and LCL 
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(LR test statistic = 1141.57, p < 0.01) model specifications improved model fit relative to the CL 
model specification yet did not differ significantly from each other (LR test statistic = 10.66, p = 
0.22).  
Considering the RPL and LCL model specifications in turn, results from the RPL model 
specification indicated that access to ART for HIV-positive persons at the time of HIV testing 
was the most important attribute to participants (relative importance weight = 2.18, 95% 
confidence interval [CI]: 1.46-2.90), and participants preferred ART to be immediately available 
for HIV-positive persons (p < 0.01). The service delivery model was the second most important 
attribute (importance weight = 1.50, 95% CI: 0.66-2.34), and participants preferred HIV testing 
at a community health campaign (p < 0.01) and counselor-administered home-based testing (p < 
0.01) over obtaining an oral fluid-based self-test at a local pharmacy. An incentive of US $0.85 
had a relatively modest yet significant influence on participants’ choices (importance weight = 
0.50, 95% CI: 0.07-0.92). Statistically significant standard deviations for preference estimates 
revealed heterogeneity in preferences for the service delivery model, access to ART for HIV-
positive persons at the time of testing, and the alternative to opt-out of HIV testing.   
Results from the LCL model specification were broadly consistent with findings from the 
RPL model specification. To facilitate interpretation of the preference patterns for each latent 
class, we plotted the preference estimates for each latent class in Figure 6.  Preference estimates 
for the latent class that included 57% of participants bore some similarities to the mean 
preferences estimates from the RPL model specification. The most important attribute to 
participants in this class was access to ART for HIV-positive persons at the time of testing 
(importance weight = 3.09, 95% CI: 2.06-4.13), followed by the availability of multi-disease 
testing (importance weight = 2.42, 95% CI: 0.42-4.43), and the service delivery model 
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(importance weight = 2.04, 95% CI: 0.95-3.14). The provision of an incentive was not found to 
significantly influence the choices of participants in this class. However, an incentive was 
important to participants belonging to the second latent class that included 30% of participants 
(importance weight = 1.09, 95% CI: 0.37-1.80). Moreover, an incentive was the only attribute 
that was found to significantly influence participant choices for this latent class. The preferences 
of the third latent class that included 13% of participants were also distinctive. The service 
delivery model was the most important attribute for this latent class (importance weight = 5.17, 
95% CI: 1.62-8.71) and participants in this latent class preferred HIV self-testing using an oral 
fluid-based test obtained at a local pharmacy over counselor-administered home-based testing (p 
<0.01) and HIV testing at a community health campaign (p <0.01). Access to ART for HIV-
positive persons was also an important attribute to participants in the third latent class 
(importance weight = 4.50, 95% CI: 2.55-6.44), although the availability of multi-disease testing 
and the provision of an incentive were not. The third latent class also appeared to have a smaller 
disutility for the alternative to opt-out of HIV testing.  
Covariate Analyses 
Subgroup analyses conducted using the CL model specification indicated differences in 
stated preferences for attributes of HIV testing according to participants’ self-perceived risk of 
acquiring HIV and self-reported sexual behaviors in the past 12 months (Table 10). Participants 
with a moderate to high self-perceived risk of acquiring HIV were less likely to prefer HIV 
testing at a community health campaign and were more likely to prefer counselor-administered 
home-based testing (p = 0.02), the availability of multi-disease testing (p = 0.02), and the 
provision of an incentive (p = 0.02). Participants who had 2 or more sexual partners or who had 
at least one paid sexual partner in the past 12 months were less likely to prefer HIV testing at a 
community health campaign (p < 0.01) and were more likely to prefer HIV self-testing using an 
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oral fluid-based test obtained at a local pharmacy (p = 0.05) and the availability of multi-disease 
testing (p < 0.01). The analyses did not reveal significant differences in participants’ stated 
preferences for attributes of HIV testing according to participants’ demographic characteristics 
or history of HIV testing in the past 12 months.   
Subgroup analyses conducted using the RPL model specification did not reveal 
significant differences in participants’ stated preferences for attributes of HIV testing that could 
be attributed to participant characteristics (Table 11). However, participants aged 18-29 years (p 
= 0.02) and those who did not have a history of testing for HIV in the past 12 months (p < 0.01) 
demonstrated a stronger disutility for the alternative to opt-out of HIV testing, suggesting that 
they assigned, on average, greater value to the HIV testing alternatives presented in the DCE 
relative to their counterparts (i.e. older men and men who had tested for HIV in the past 12 
months).  
Individual characteristics of participants were not found to predict latent class 
membership (Table 12). Neither unadjusted nor adjusted odds ratios estimated from multinomial 
logit models were statistically significant for any of the individual characteristics that were used 
to define subgroups for the CL and RPL model specifications.  
3.4. Discussion 
This study yields several conclusions regarding heterogeneity in men’s preferences for 
attributes of community-based HIV testing that may be useful for policymakers who seek to 
promote male testing. Our first and most evident finding is that men’s preferences for attributes 
of community-based HIV testing are heterogeneous. Both the RPL and LCL model 
specifications revealed preference heterogeneity and considerably improved model fit by 
allowing preferences to vary across individual participants and participant groups, respectively. 
Second, we found that even though preferences were heterogeneous, our results were broadly 
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consistent across model specifications suggesting that each model specification reliably estimates 
preferences at the population-level. Results from the different model specifications also 
suggested certain preferences that are largely homogenous. For instance, we found that men 
assigned a disutility to opting out of HIV testing across all model specifications. We also found 
that immediate access to ART for HIV-positive persons was strongly preferred across all model 
specifications, save for a single latent class for whom this attribute was not significant under the 
LCL specification. Third, our results strongly suggest that there is room for policymakers to 
harness preference heterogeneity to enhance the delivery of community-based HIV testing to 
promote uptake by men. The discovery of a latent class of participants who preferred HIV self-
testing over other service delivery models for HIV testing is very compelling, particularly 
because the service delivery model was the most influential attribute for participants in this latent 
class and participants in this class had the weakest disutility for opting out of HIV testing. 
Although we cannot definitively say that HIV self-testing is preferred by men who have less 
utility for HIV testing in general, our results beg further investigation of the possibility. The 
discovery of a latent class for whom a financial incentive was the single influential attribute is 
also intriguing. This finding suggests that providing financial incentives could be an effective 
way to make HIV testing more appealing to certain men and issues a strong call for further 
resolution of individual characteristics associated with latent class membership so that 
policymakers might more effectively target incentivized testing interventions. 
Our work contributes to broader health policy dialogues in two important ways. First, we 
add evidence to demonstrate that understanding preference heterogeneity is important for policy 
pertaining to ways to increase uptake of HIV testing. Although the importance of heterogeneity 
in clinical outcomes has been well recognized, the role of preference heterogeneity in response to 
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policies and public health interventions has been less clear (85,86). Yet, just as knowledge of 
heterogeneity of treatment effects has led to gains in the clinical effectiveness of treatment 
strategies, understanding preference heterogeneity provides opportunities to enhance the 
effectiveness of health policies and interventions. A growing body of literature demonstrates that 
investigating heterogeneity in stated preferences provides great opportunity to anticipate and 
understand heterogeneity in revealed preferences (i.e. health behaviors), and we show how a 
range of econometric modeling techniques can be used to investigate heterogeneity in men’s 
preferences for attributes of community-based HIV testing (87–90). Additionally, our work 
speaks to the importance of targeting in HIV program planning in sub-Saharan Africa, an issue 
that has received recent, high-level recognition in the HIV/AIDS literature and that holds 
intuitive appeal from a cost-effectiveness perspective (86,91,92). Innovative research to locate 
populations at high risk of acquiring HIV through geospatial analysis and to deliver 
geographically-targeted interventions is currently being advanced under the rationale that 
preventive interventions that reach populations most vulnerable to acquiring HIV are likely to be 
effective and cost-effective approaches to reduce HIV transmission (91,92). We show that stated 
preference research provides another approach to determine how to target populations who lack 
engagement with preventive services and who could be at risk of acquiring HIV. Moreover, a 
stated preference approach allows for the comparison of a range of strategies and can reveal how 
single or a mix of strategies might be optimal to reach vulnerable populations. 
We acknowledge several limitations of our study. First, we strongly suspect the DCE was 
underpowered to detect differences in participants’ preferences that can be attributed to 
participant characteristics for the RPL and LCL model specifications. Although subgroup 
analyses conducted using the CL model specification pointed to differences in preferences 
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according to participants’ self-perceived risk of HIV and self-reported sexual behaviors in the 
past 12 months, we ruled out the CL as a preferred model specification, given that it relies on 
assumptions that are unlikely to hold for our population and was dominated by both the RPL and 
LCL model specifications in measures of goodness of fit. Covariate analyses conducted using the 
RPL and LCL model specifications yielded few significant results and none with regard to 
preferences for attributes of community-based HIV testing. Our analyses to investigate 
heterogeneity according to observed characteristics of participants are therefore inconclusive.  
This limitation is major, as we cannot make links between the heterogeneity that we detected in 
our analyses to observed characteristics of men that could inform how HIV testing can be 
targeted to defined subgroups. Second, our exclusion criteria and sampling strategy could have 
led to underrepresentation of men who are frequently away from their home communities and the 
generalizability of our results could be limited for certain subpopulations. Third, our work is 
premised on the assumption that stated preferences are concordant with revealed preferences. 
Evidence upholds the external validity of DCEs to predict actual choices, yet this is an area for 
further research (25).  
Despite these limitations, this study makes key strides to advance understanding of 
heterogeneity in men’s preferences for attributes of community-based HIV testing. Our results 
add dimensionality to population-level preference patterns and indicate that there is room to 
harness heterogeneity to more effectively target community-based HIV testing to promote uptake 
by men. We provide a methodological example for investigating unobserved and observed 
preference heterogeneity and pave the way for further investigation of linkages between the two. 
 
 
Table 4. Attributes and Levels Included in the DCE 
Attribute  Levels 
Service delivery model - You attend a community health event in your village 
- A health counselor comes to your home and offers to test you for HIV 
- You pick up a self-test kit at a nearby pharmacy 
Availability of multi-disease 
testing services 
- You can test for tuberculosis, malaria, pressure and diabetes when you test for HIV a  
- Only HIV testing is available 
Access to ART for HIV-
positive persons 
- Medications to treat HIV are immediately available 
- Medications to treat HIV are not immediately available 
Provision of an incentive for 
HIV testing 
- You receive 3,000 Shillings when you test for HIV 
- You do not receive compensation 







Table 5. Participant Subgroups 
 
N (%) 
Total participants a 194 
Age (years) 
18 - 29 years  65 (34) 
≥ 30 years 129 (66) 
Marital status  
Never married  51 (26) 
Married/cohabitating/divorced/widowed 143 (74) 
Highest level of education attained  
Primary or less 136 (70) 
Beyond primary 14 (30) 
Tested for HIV in the past 12 months  
No 91 (47) 
Yes 103 (53) 
Self-perceived risk of having HIV b 
No or low risk 154 (81) 
Moderate to high risk 35 (19) 
Self-reported sexual behavior in the past 12 months  
0-1 nonpaid partners 147 (76) 
≥2 partners or at least 1 paid partner 46 (24) 
a Excludes 9 participants who self-reported a seropositive status at enrollment. 
b Excludes 5 participants who self-reported an unknown risk of having HIV. 
 
Table 6. Conditional Logit Model Estimation of Preferences 
Variables β SE 
HIV testing at a community health campaign  0.96** (0.35) 
Home-based testing  0.13 (0.18) 
HIV self-testing  -1.09*** (0.26) 
Multi-disease testing is available -0.08 (0.27) 
ART is immediately available  1.04*** (0.12) 
An incentive of US $0.85 is provided 0.25 (0.15) 
Would not test for HIV  -4.17*** (0.25) 
Number of choices 2,910  
Number of participants 194  
Results are reported as mean coefficients with robust standard errors in parentheses; *** 




Table 7. Random Parameters Logit Model Estimation of Preferences 




HIV testing at a community health 
campaign  
0.64** (0.25) 1.13*** (0.30) 
Home-based testing  0.21 (0.13) 0.49* (0.23) 
HIV self-testing  -0.86*** (0.20) 1.62*** (0.40) 
Multi-disease testing is available 0.17 (0.20) 0.09 (0.25) 
ART is immediately available  1.09*** (0.18) 1.12*** (0.17) 
An incentive of US $0.85 is provided 0.25* (0.11) 0.33 (0.39) 
Would not test for HIV  -7.46*** (1.36) 3.63*** (0.79) 
Number of choices 2,910    
Number of participants 194    
Results are reported as mean coefficients and standard deviations with robust standard errors 
in parentheses; *** p<0.001, ** p<0.01, * p<0.05. ART, antiretroviral therapy. 
 
Table 8. Latent Class Logit Model Estimation of Preferences 
 Class 1   Class 2   Class 3  
Variables β SE  β SE  β SE 
HIV testing at a community health 
campaign  
0.23 (0.49)  0.26 (0.29)  -2.56* (1.00) 
Home-based testing  0.91** (0.30)  0.10 (0.14)  -0.05 (0.36) 
HIV self-testing   -1.13** (0.43)   -0.35 (0.28)  2.61** (0.84) 
Multi-disease testing is available 1.21* (0.51)  0.18 (0.20)  0.30 (0.56) 
ART is immediately available  1.55*** (0.26)  -0.10 (0.14)  2.25*** (0.50) 
An incentive of US $0.85 is provided 0.23 (0.30)  0.54** (0.18)  -0.33 (0.38) 
Would not test for HIV  -4.57*** (0.67)  -4.41*** (0.73)  -1.70*** (0.46) 
Constant 0.66** (0.25)     -0.84* (0.36) 
Probability of class membership          
Class 1 0.575        
Class 2 0.297        
Class 3 0.127        
Number of choices 2,910        
Number of participants 194        
Results are reported as mean coefficients for each class with robust standard errors in parentheses; *** p<0.001, ** 








Table 9. Goodness-of-Fit Measures 







Conditional logit 2212.95 2248.81 -1100.48 RPL vs. CL 1130.91 <0.001 
Random parameters 
logit 
1094.05 1165.76 -535.02 LCL vs. CL 1141.57 <0.001 
Latent class logit 1099.39 1218.91 -529.69 LCL vs. RPL 10.66 0.2217 
AIC, Akaike information criterion; BIC, Bayesian information criterion; CL, conditional logit; RPL, random parameters logit; LCL, 





Figure 6. Importance of Attributes on Choices Made by Men from Three Latent Classes 























































































































Table 10. Subgroup Analyses Conducted with the Conditional Logit Model 
Covariate defining subgroup Aged 18-29 years  Single (never married)  
Primary education or 
less 
Variables β SE  β SE  β SE 
HIV testing at a community health campaign 0.98** (0.43)  0.96*** (0.33)  1.07*** (0.38) 
Home-based testing  0.17 (0.23)  0.16 (0.18)  0.06 (0.18) 
HIV self-testing  -1.16*** (0.33)  -1.12*** (0.27)  -1.13*** (0.23) 
Multi-disease testing is available -0.19 (0.33)  -0.11 (0.25)  -0.10 (0.25) 
ART is immediately available for HIV-
positive persons 
1.15*** (0.17)  1.09*** (0.15)  1.06*** (0.15) 
An incentive of US $0.85 is provided 0.26 (0.19)  0.23 (0.17)  0.09 (0.21) 
Would not test for HIV  -4.07*** (0.24)  -4.07*** (0.24)  -3.55*** (0.33) 
Interactions         
Community health campaign * Covariate -0.16 (0.27)  -0.04 (0.19)  -0.10 (0.37) 
Home-based testing * Covariate -0.14 (0.14)  -0.09 (0.08)  0.03 (0.19) 
HIV self-testing * Covariate 0.31 (0.38)  0.13 (0.24)  0.07 (0.54) 
Multi-disease testing * Covariate 0.32 (0.18)  0.11 (0.16)  0.04 (0.17) 
Immediate ART * Covariate -0.27 (0.16)  -0.17 (0.13)  -0.02 (0.22) 
Incentive * Covariate -0.01 (0.19)  0.09 (0.13)  0.22 (0.27) 
Would not test for HIV * Covariate -0.30 (0.24)  -0.28 (0.16)  -0.40 (0.22) 
Number of choices 2,910 
 
 2,910   2,910  
Number of participants 194   194   194  






Table 10. Subgroup Analyses Conducted with the Conditional Logit Model (continued) 
Covariate defining subgroup 
Has not tested for 
HIV in the past 12 
months 
 
Perceived risk of HIV 
is moderate or high 
 
Had ≥2 sexual partners 
or paid for sex in the 
past 12 months 
Variables β SE  β SE  β SE 
HIV testing at a community health campaign 0.87** (0.35)  1.12*** (0.35)  1.15*** (0.38) 
Home-based testing  0.16 (0.19)  0.00 (0.19)  0.05 (0.20) 
HIV self-testing  -1.03*** (0.20)  -1.12*** (0.25)  -1.20*** (0.29) 
Multi-disease testing is available -0.00 (0.27)  -0.22 (0.27)  -0.22 (0.30) 
ART is immediately available for HIV-positive 
persons 
0.98*** (0.15)  1.11*** (0.14)  1.05*** (0.14) 
An incentive of US $0.85 is provided 0.29** (0.14)  0.21 (0.17)  0.26 (0.18) 
Would not test for HIV  -4.10*** (0.47)  -3.98*** (0.25)  -4.19*** (0.21) 
Interactions         
Community health campaign * Covariate 0.18 (0.23)  -0.33** (0.14)  -0.55*** (0.20) 
Home-based testing * Covariate 0.04 (0.20)  0.23*** (0.07)  -0.07 (0.13) 
HIV self-testing * Covariate -0.22 (0.42)  0.10 (0.19)  0.62* (0.32) 
Multi-disease testing * Covariate -0.18 (0.19)  0.21** (0.09)  0.47*** (0.16) 
Immediate ART * Covariate 0.15 (0.15)  -0.21 (0.12)  0.05 (0.13) 
Incentive * Covariate -0.10 (0.08)  0.22** (0.10)  -0.07 (0.13) 
Would not test for HIV * Covariate -0.07 (0.32)  -0.45 (0.30)  0.06 (0.16) 
Number of choices 2,910 
 
 2,835   2,895  
Number of participants 194   189   193  








Table 11. Subgroup Analyses Conducted with the Random Parameters Logit Model 
Covariate defining subgroup Aged 18-29 years  Single (never married)  
Primary education 
or less 
Variables β SE  β SE  β SE 
HIV testing at a community health campaign 0.53 (0.31)  0.60* (0.30)  0.90 (0.51) 
Home-based testing  0.39* (0.18)  0.32* (0.16)  0.10 (0.24) 
HIV self-testing  -0.92*** (0.24)  -0.92*** (0.25)  -1.00** (0.39) 
Multi-disease testing is available 0.24 (0.25)  0.26 (0.25)  -0.10 (0.37) 
ART is immediately available for HIV-positive 
persons 
1.34*** (0.26)  1.23*** (0.25)  1.11*** (0.29) 
An incentive of US $0.85 is provided 0.33* (0.14)  0.24 (0.14)  0.07 (0.23) 
Would not test for HIV  -6.96*** (1.64)  -7.30*** (1.84)  -6.61*** (1.40) 
Interactions         
Community health campaign * Covariate -0.10 (0.97)  0.02 (0.99)  -0.55 (1.01) 
Home-based testing * Covariate -0.71 (0.41)  -0.56 (0.46)  -0.00 (0.44) 
HIV self-testing * Covariate 0.82 (1.25)  0.54 (1.33)  0.55 (1.33) 
Multi-disease testing * Covariate 0.26 (0.97)  -0.17 (1.00)  0.97 (0.89) 
Immediate ART * Covariate -0.57 (0.55)  -0.62 (0.61)  0.17 (0.57) 
Incentive * Covariate -0.29 (0.50)  0.01 (0.51)  0.60 (0.53) 
Would not test for HIV * Covariate -3.20* (1.32)  -2.39 (1.23)  -0.76 (1.17) 
Number of choices 2,910 
 
 2,910   2,910  
Number of participants 194   194   194  







Table 11. Subgroup Analyses Conducted with the Random Parameters Logit Model (continued) 
Covariate defining subgroup 
Has not tested for 
HIV in the past 12 
months 
 
Perceived risk of HIV 
is moderate or high 
 
Had ≥2 sexual 
partners or paid for 
sex in the past 12 
months 
Variables β SE  β SE  β SE 
HIV testing at a community health campaign 0.48 (0.34)  0.79** (0.30)  0.95** (0.31) 
Home-based testing  0.21 (0.16)  0.14 (0.16)  0.12 (0.15) 
HIV self-testing  -0.70* (0.28)  -0.93*** (0.24)  1.07*** (0.25) 
Multi-disease testing is available 0.33 (0.30)  0.11 (0.24)  0.01 (0.22) 
ART is immediately available for HIV-positive 
persons 
0.98*** (0.25)  1.21*** (0.24)  1.15*** (0.22) 
An incentive of US $0.85 is provided 0.29 (0.17)  0.23 (0.13)  0.28* (0.13) 
Would not test for HIV  -4.88*** (0.95)  -6.65*** (1.35)  -7.44*** (1.59) 
Interactions         
Community health campaign * Covariate 1.19 (1.04)  -0.93 (1.64)  -2.02 (1.23) 
Home-based testing * Covariate 0.60 (0.54)  0.35 (0.57)  -0.46 (0.49) 
HIV self-testing * Covariate -1.78 (1.43)  0.58 (2.05)  2.48 (1.59) 
Multi-disease testing * Covariate -0.37 (0.91)  2.52 (3.23)  1.96 (1.74) 
Immediate ART * Covariate 1.77 (1.27)  0.51 (2.15)  0.32 (0.81) 
Incentive * Covariate -0.20 (0.63)  0.26 (1.44)  -0.39 (0.58) 
Would not test for HIV * Covariate -31.69** (9.72)  -3.13 (6.78)  -0.56 (1.37) 
Number of choices 2,910 
 
 2,835   2,895  
Number of participants 194   189   193  







Table 12. Unadjusted and Adjusted Odds Ratios (aOR) and 95% Confidence Intervals (CI) for Characteristics Associated with Class 
Membership a 






(n = 48) 
 
Class 3 
(n = 21) 
Characteristic n (%)  OR (95% CI) aOR (95% CI)  OR (95% CI) aOR (95% CI) 
Age         
   18 - 29 years  65 (34)  Ref. Ref.  Ref. Ref. 
   ≥ 30 years 129 (66)  0.57 (0.28 – 1.13) 0.70 (0.25 - 1.94)  0.54 (0.21 – 1.39) 0.48 (0.13 - 1.73) 
Marital status        
   
Married/divorced/separate
d 
143 (74)  Ref. Ref.  Ref. Ref. 
   Never married 51 (26)  1.90 (0.92 – 3.93) 1.73 (0.61 - 4.93)  1.39 (0.49 – 3.92) 0.86 (0.21 - 3.53) 
Educational level        
    Primary or less  136 (70)  Ref. Ref.  Ref. Ref. 
    Beyond primary 58 (30)  0.85 (0.40 – 1.79) 0.70 (0.32 - 1.52)  1.14 (0.43 – 3.07) 0.95 (0.35 - 2.61) 
Tested for HIV in past 
12 months 
       
   Yes 103 (53)  Ref. Ref.  Ref. Ref. 
   No 91 (47)  0.75 (0.38 – 1.47) 0.69 (0.34 - 1.41)  0.95 (0.38 – 2.41) 1.04 (0.40 - 2.69) 
Perceived risk of HIV b        
   No or low risk 154 (81)  Ref. Ref.  Ref. Ref. 
   Moderate or high risk 35 (19)  1.96 (0.86 – 4.49) 2.08 (0.84 - 5.12)  1.79 (0.58 – 5.51) 1.85 (0.48 - 7.19) 
Sexual behavior in past 
12 months c 
       
   0-1 nonpaid partners  147 (76)  Ref. Ref.  Ref. Ref. 
   2 or more partners or 
paid for sex 
46 (24)  0.82 (0.36 – 1.84) 0.50 (0.22 - 1.12)  0.95 (0.32 – 2.81) 0.68 (0.20 - 2.36) 
Number of participants 194  - 189  - 189 
a The likelihood of membership in classes 2 and 3 is compared to the likelihood of membership in class 1 (n = 125); *p<0.05.  
b Excludes 5 participants who reported an unknown risk of HIV. 










CHAPTER 4. THE COST-EFFECTIVENESS OF COMMUNITY-BASED SERVICE 
DELIVERY MODELS TO INCREASE HIV TESTING AND DIAGNOSIS AMONG 
MEN IN UGANDA  
4.1. Introduction 
Increasing HIV awareness is the first objective in a global strategy to halt HIV 
transmission. In order to end the AIDS epidemic by 2030, the Joint United Nations Program on 
HIV/AIDS (UNAIDS) has proposed the “90-90-90 targets” which urge countries to ensure that 
90% of HIV-positive persons know their status, 90% of those diagnosed with HIV are receiving 
treatment, and 90% of those receiving treatment are virally suppressed by 2020 (1). While 
considerable progress has been made to expand access to HIV testing, a number of important 
gaps in testing coverage remain including low coverage among men in sub-Saharan Africa. It is 
well recognized that men are less likely than women to test for HIV, and that HIV-positive men 
are less likely to be aware of their status and to be receiving antiretroviral treatment than HIV-
positive women (2,5,7). These disparities lead to increased morbidity and mortality for HIV-
positive men and to missed opportunities to prevent HIV transmission (4,6,8,93). 
In Uganda, the most recent update on the country’s progress toward the 90-90-90 targets 
reveals that 77% of HIV-positive persons are aware of their status (34). While over 90% of HIV-
positive women and children have been diagnosed, only 61% of HIV-positive men have been 
diagnosed (34). Men are therefore a critical population to engage in HIV testing, and national 
and bilateral actors involved in the HIV/AIDS response are actively seeking ways to enhance the 
effectiveness of testing services to increase uptake of HIV testing and HIV diagnosis among 
men. At the same time, the annual per capita expenditure on health in Uganda is $46, and interest 
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in the effectiveness of testing services to reach men must be balanced with consideration of the 
resources required to achieve improvements (94). The United States President’s Emergency Plan 
for AIDS Relief (PEPFAR), for instance, is a major source of funding for HIV/AIDS activities in 
Uganda and has made targeting men with the most efficient service delivery models for HIV 
testing a strategic priority for 2018 (95).  
A recent systematic review and meta-analysis revealed that community-based delivery of 
HIV testing—which  includes approaches such as home-based testing, community health 
campaigns, and HIV self-test provision—achieves higher uptake of HIV testing by men than 
standard facility-based testing (18). The accessibility and convenience of community-based 
service delivery models for HIV testing likely appeal to men and reduce barriers related to travel, 
costs, and stigma (22,23). Community-based service delivery models are also more effective at 
diagnosing individuals with high CD4 counts and thus hold great potential to avert large health 
decrements for HIV-positive men and to prevent HIV transmission (18,21). For these reasons, 
community-based service delivery models are a compelling approach to expand male testing. For 
policymakers who seek to optimize the allocation of resources to increase HIV awareness among 
men and achieve the 90-90-90 targets, there is a vital need to evaluate the cost-effectiveness of 
community-based service delivery models to increase HIV testing and diagnosis among men. 
Previous studies have investigated the effectiveness and costs of various community-
based service delivery models to promote HIV testing in sub-Saharan Africa (18,21,36,96–101). 
However, differences in the populations targeted with HIV testing and the methods used to 
assess uptake and costs associated with service delivery models implemented across diverse 
contexts have made it challenging to evaluate the cost-effectiveness of community-based service 
delivery models to promote HIV testing and HIV diagnosis among men in sub-Saharan Africa. 
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Additionally, high-level modeling studies have been conducted that investigate the cost-
effectiveness of increasing HIV testing coverage relative to other interventions that could be 
conducted to enhance the delivery of services and promote patient engagement along the cascade 
of HIV/AIDS treatment and care (102,103). Yet these studies make broad assumptions about 
increases in testing coverage without considering the operational capacities and variation in 
demand that are associated with specific service delivery models for HIV testing. 
In this study, we investigate the cost-effectiveness of three community-based service 
delivery models to increase HIV testing and diagnosis among men in rural Uganda. Each of the 
service delivery models has strong potential to appeal to men in rural Uganda, and we predicted 
uptake of HIV testing using results from a discrete choice experiment (DCE) that we previously 
conducted. A DCE is a choice-based survey to elicit preferences for attributes of a service or 
product; results from a DCE can be used to predict uptake of the service or product 
(27,30,33,41). Using uptake predictions from a DCE ensured that we have consistent measures 
of testing uptake across different service delivery models for a representative sample of men in 
Uganda.1 Additionally, we applied a comparative framework to consistently assess the costs 
associated with each service delivery at a steady operational state. 
To our knowledge, our analysis is the first to evaluate the cost-effectiveness of multiple 
community-based service delivery models to increase HIV testing and diagnosis among men in 
sub-Saharan Africa, and our work advances the literature in two important ways. First, our use of 
a DCE to generate uptake parameters is innovative and allowed us to estimate uptake for existing 
service delivery models as well as predict uptake for a service delivery model that is new to the 
                                                 
1We estimated uptake of HIV testing for a sample of men who are representative of the adult male population in 
rural Uganda, and the DCE provided an environment, albeit an artificial environment, in which all participants made 
choices between alternatives from a consistent range of possibilities. Our estimates of HIV testing uptake are 
therefore equivalent to estimates of testing coverage. 
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testing landscape. Oral fluid-based HIV self-tests are not yet widely available in Uganda. 
However, the World Health Organization (WHO) has recently called for the expanded use of 
HIV self-tests as novel tools to promote HIV testing (43), and we deliver the first evidence of 
men’s demand for an innovative service delivery model that makes use of HIV self-tests to 
promote testing in Uganda. Second, we investigated the cost-effectiveness of community-based 
service delivery models to not only increase HIV testing by men but to also diagnose HIV among 
men previously unaware of their HIV status. Many efforts to attain the first 90-90-90 target have 
focused on expanding testing coverage among the population at large with the rationale that as 
testing coverage expands so too will HIV awareness (104,105). Yet, it is essential to evaluate the 
effectiveness of alternative service delivery models to not only increase HIV testing but to also 
increase HIV diagnosis. We incorporated variation in the probabilities that men would test 
positive and be newly diagnosed with HIV under each service delivery model and reveal how 
important differences emerge when evaluating the cost-effectiveness of alternative service 
delivery models according to each outcome. Our results hold important implications for the 
design and delivery of community-based service delivery models for HIV testing.  
4.2. Methods 
Model Structure 
We constructed a decision analytic model to compare the costs and testing outcomes 
associated with three community-based service delivery models that have strong potential to 
increase HIV testing by men in sub-Saharan Africa (Figure 7). We compared: 1) HIV testing at 
multi-disease community health campaigns (CHC); 2) home-based testing (HBT) in which 
health counselors make door-to-door visits to homes in a community and offer to test household 
members for HIV; and 3) the distribution of oral fluid-based HIV self-tests at local pharmacies 
(HIVST). We evaluated outcomes over a one-year horizon when a single community-based 
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service delivery model for HIV testing is made available relative to a status quo scenario in 
which no community-based service delivery model for HIV testing is provided. The analytical 
cohort consisted of adult (≥18 years) male residents of rural Uganda. We excluded urban 
residents from the analytical cohort as they have greater access to health facilities and different 
livelihoods than rural residents.  
Our outcomes of interest were uptake of HIV testing and new HIV diagnoses. We 
modeled the proportion of our cohort that tested for HIV and that tested HIV-positive under each 
service delivery model. We accounted for the sensitivity and specificity of the diagnostics used 
by each service delivery model to detect HIV. Additionally, we estimated the proportion of HIV-
positive test results that constituted new HIV diagnoses as some service delivery models could 
attract individuals who already know their HIV status. For instance, HIV testing is integrated 
with testing for other diseases at community health campaigns. Integration of testing services can 
help reduce HIV-related stigma, and individuals who already know that they are HIV-positive 
have been found to use CHC (23,40,100).  
Model Parameters 
Costs 
We estimated the costs to deliver HIV testing under each service delivery model from a 
programmatic perspective. To ensure comparability across service delivery models, we 
accounted for the total costs essential to implement each service delivery model at a steady state 
of operation. We excluded start-up and quality control costs that are important in practice yet are 
not steady-state operational costs. We assumed that each service delivery model operated within 
an existing organizational infrastructure and included costs specific to each service delivery 
model associated with personnel, transportation, equipment, building rentals, overhead, and 
community mobilization to inform residents of the availability of HIV testing. 
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CHC and HBT are service delivery models that have been implemented in Uganda. We 
obtained estimates of the costs of providing HIV testing under these service delivery models 
from peer-reviewed literature. We searched for studies that investigated the implementation of 
these service delivery models at scale (at or above the parish-level) and that provided sufficient 
detail to ensure the quality of the costing methods employed. We used random-effects meta-
analysis to pool estimates when estimates were available from multiple studies that met these 
criteria.  
HIVST is a novel service delivery model that has not yet been implemented widely in 
Uganda, and we employed a micro-costing approach to estimate the costs of implementing this 
service delivery model for a representative rural district. We assumed that a public sector 
organization (e.g. a governmental or non-governmental organization) would oversee 
implementation and partner with local pharmacies to distribute self-tests free-of-charge to rural 
residents. We consulted the National Drug Authority of Uganda for a list of licensed pharmacies 
in the district and obtained a price quote for the cost to procure a bulk order of OraQuick HIV 
self-tests (OraSure Technologies, Inc.) under a low-cost charitable support agreement with the 
Bill and Melinda Gates Foundation (106). We consulted program expenditure records for 
existing community-based HIV testing programs to estimate fuel and vehicle costs to deliver 
HIV self-tests to pharmacies and to estimate personnel, overhead, and building rental costs. A 
breakdown of the total costs for HIVST is presented in Appendix C.  
We reported all costs in 2016 USD. Costs that were reported in prior years were 
converted to Ugandan shillings using the exchange rate that the authors reported, inflated using 
Ugandan consumer price indices to their 2016 value, then converted to USD at the 2016 official 
exchange rate. We did not use a purchasing power parity index for cost conversion as all costs 
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were specific to Uganda and reporting of costs at the official exchange rate allows our results to 
be more readily compared to costs previously reported in peer-reviewed literature.2 We did not 
apply a discount factor as the analytical time horizon was limited to one year.  
Population parameters and probabilities of HIV testing and diagnosis 
We estimated the size of the adult male population of rural Uganda using national 
population projections (107). The probabilities that men would test for HIV under each service 
delivery model were estimated from a DCE (80). The DCE investigated men’s preferences for 
attributes of community-based service delivery models for HIV testing and was administered to a 
random sample of 203 adult male residents from four parishes of Mbarara District, a rural district 
in southwestern Uganda. We used the results of the DCE to predict uptake of HIV testing under 
each of the service delivery models investigated in this analysis. To strengthen confidence in our 
uptake predictions, we calibrated the uptake predictions from the DCE to match reference values 
of uptake of HIV testing by men under existing service delivery models that have been reported 
in the peer-reviewed literature (64).3  
The probabilities that men tested HIV-positive and were newly diagnosed with HIV were 
obtained from peer-reviewed literature for CHC and HBT. We focused our search of the 
literature on studies that investigated the implementation of these service delivery models at 
scale in Uganda and provided sex-disaggregated estimates. We pooled estimates using random 
effects meta-analysis when multiple estimates were available for a single parameter.  
                                                 
2Additionally, one important cost component for HIVST was the procurement of OraQuick self-tests from OraSure 
Technologies under a charitable support agreement with the Bill and Melinda Gates Foundation. This agreement 
allows for low-cost procurement of self-tests in developing countries. Using a purchasing power index to convert 
this cost to international dollars would not have the effect that it is intended to have.  
3Prediction and calibration of testing uptake have been previously described in greater detail in Chapter 2 and 
Appendix B.   
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The probabilities that men who use HIVST would test HIV-positive and be newly 
diagnosed with HIV are unknown, and we had to make assumptions about the base case values 
for these parameters. We estimated the probability that men would test HIV-positive under 
HIVST as a function of the HIV prevalence among testers and the sensitivity and specificity of 
OraQuick HIV self-tests (108).4 We assumed that the HIV prevalence among men who use 
HIVST would be the same as the adult male HIV prevalence. We further assumed that all men 
who test HIV-positive under HIVST would not already know that they were HIV-positive and 
would thus be newly diagnosed with HIV. Base case parameter inputs are presented for each 
service delivery model in Table 13. 
4.3. Analyses 
Base Case Analyses 
We used the decision analytic model to estimate the total costs, number of men who 
tested for HIV, and number of men newly diagnosed with HIV under each service delivery 
model. We then calculated incremental cost-effectiveness ratios (ICERs) to compare the cost-
effectiveness of the service delivery models. ICERs express the difference in costs in ratio to the 
difference in health benefit that one service delivery model provides relative to another. We 
estimated one set of ICERs to assess the cost per additional man who tested for HIV and another 
set to assess the cost per additional man newly diagnosed with HIV. ICERs were calculated for 
each service delivery model relative to the next less costly service delivery model, except for the 
least costly service delivery model for which ICERs were calculated relative to the status quo 
scenario where no community-based service delivery model was provided (109). When one 
service delivery model was more costly yet less effective than another service delivery model, it 
                                                 
4This value was adjusted to account for false positive results.  
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was considered dominated and eliminated from consideration as a cost-effective alternative 
(109).  
Although there is considerable interest in identifying efficient service delivery models to 
expand access to HIV testing to attain the first UNAIDS 90-90-90 target, the amount that 
decision-makers are willing to pay to increase HIV testing or HIV diagnosis is unknown. 
Furthermore, the HIV/AIDS response in Uganda is heavily supported by international funders, 
and it is possible that the various actors engaged in HIV/AIDS activities in Uganda have 
different willingness-to-pay (WTP) thresholds to realize improvements in testing outcomes. 
Therefore, we did not compare the ICERs we calculated to benchmark WTP thresholds. Instead, 
we used the ICERs to rank order the alternatives, eliminate dominated alternatives, and reveal 
what decision makers must be willing to pay for each remaining service delivery model to be 
considered the most cost-effective alternative. 
Deterministic Sensitivity Analyses 
The field of community-based HIV testing has evolved and continues to evolve rapidly, 
and several parameters that we included in our decision analytic model were uncertain or subject 
to change. We performed deterministic sensitivity analyses to assess the impact of modifying the 
base case values for the most uncertain and volatile parameters in the decision analytic model. 
We performed one-way sensitivity analyses for single parameters and two-way sensitivity 
analyses when it was possible for two parameters to shift in tandem. We describe our 




The probability that men who use HIVST will be HIV-positive is unknown, and we 
shifted the probability of testing HIV-positive under HIVST three percentage points below and 
above the base case value that was approximated using the regional adult male HIV prevalence. 
The probability that men who test HIV-positive under HIVST will be newly diagnosed with HIV 
is also unknown. For our base case scenario, we assumed that men would not use HIVST if they 
had already been diagnosed with HIV. However, repeat testing by HIV-positive persons to 
confirm prior test results has been observed in other testing contexts (110), and we assessed the 
impact on our base case results if 30% of men who tested HIV-positive under HIVST were 
previously diagnosed with HIV. Additionally, oral fluid-based HIV self-tests are new to market 
in sub-Saharan Africa and the cost to procure the self-tests is subject to considerable fluctuation. 
A charitable support agreement currently allows for procurement of OraQuick HIV Self-Tests at 
reduced cost in developing countries (106). Yet, in the absence of such an agreement, the cost to 
procure self-tests could easily be much higher. We doubled the cost of HIVST to examine the 
impact that higher procurement costs could have on our base case results.   
HBT 
Non-disclosure of prior HIV diagnosis before HBT has been observed in other contexts, 
and it is possible that not all positive test results under this service delivery model constitute new 
HIV diagnoses (111). We assessed the impact on our base case results if 30% of men who tested 
HIV-positive under HBT did not disclose a prior HIV diagnosis. Furthermore, higher uptake of 
HIV testing under HBT has been reported in peer-reviewed literature than the testing uptake that 
we predicted from the DCE. Asiimwe et al. (2017) investigated HBT in Sheema, a rural district 
that borders Mbarara District, and estimated that 69% of the adult population tested for HIV 
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(96). We anticipate that the uptake reported by Asiimwe et al. (2017) is high as the authors 
assumed all persons previously diagnosed with HIV refrained from testing and excluded the 
share of the population already diagnosed with HIV from their estimate of testing coverage. Yet, 
it is possible that higher uptake of HBT can be achieved than what we predicted, and we shifted 
the uptake estimate for this service delivery model to 69% as a high-end estimate of what might 
be possible.  
CHC 
Community health campaigns provide flexible platforms for delivering HIV testing along 
with other health services, and it is possible that improvements can be made to this service 
delivery model to promote male testing. During the DCE, we investigated how stated preferences 
for CHC change when small, monetary incentives of 3,000 Ugandan shilling (approximately 
US$ 0.85) are provided. We also investigated how stated preferences change when antiretroviral 
therapy (ART) is provided on-site for HIV-positive persons. We found that the predicted uptake 
of CHC increased when each of these changes was implemented. For this study, we estimated 
the additional costs that would be required to offer incentives and provide immediate access to 
ART for HIV-positive persons as interventions to promote HIV testing (a summary can be found 
in Appendix D). We then conducted two-way sensitivity analyses to evaluate the impact that 
these interventions are likely to have on the cost-effectiveness of CHC to increase HIV testing 
and diagnosis among men.    
Probabilistic Sensitivity Analysis 
 To account for uncertainty underlying all model parameters, we performed probabilistic 
sensitivity analysis. We assigned a beta distribution to model parameters that constituted 
probabilities and a gamma distribution to all cost parameters and conducted a Monte Carlo 
simulation with 1,000 draws (Crystal Ball, Oracle Corporation, Redwood Shores, CA). Given 
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that there are not established WTP thresholds to improve uptake of HIV testing and HIV 
diagnosis among men and that WTP could vary across decision makers, we used a net monetary 
benefit framework to compare the net monetary benefits of each service delivery model over a 
range of WTP thresholds and plotted our results as cost-effectiveness acceptability curves 
(CEACs) which represent the likelihood that each service delivery model is the most cost-
effective alternative over a range of WTP thresholds (112).  
4.4. Results 
Base Case Results 
The total annual costs to implement a single community-based service delivery model to 
promote HIV testing among a population of 5,206,236 adult male residents of rural Uganda 
ranged from US $8,363,298 to $29,788,000. The number of men who tested for HIV under each 
service delivery model ranged from 1,665,996 to 3,331,991 (33-64% of the adult male 
population), and the number of men who were newly diagnosed with HIV ranged from 75,885 to 
113,288 (1.5-2.2% of the adult male population). HIVST was the least costly service delivery 
model and resulted in the fewest men who tested for HIV yet yielded a considerable number of 
men who were newly diagnosed with HIV. HBT was more costly and resulted in more men who 
tested for HIV yet yielded fewer men who were newly diagnosed with HIV than HIVST and was 
therefore dominated by HIVST. CHC was the service delivery model with the greatest total costs 
and resulted in the greatest number of men who tested for HIV and who were newly diagnosed 
with HIV. These results produce the efficiency frontiers presented in Figures 8 and 9. 
The total costs and effectiveness, along with the ICERs associated with the alternative 
community-based service delivery models to increase HIV testing and identify previously 
undiagnosed cases of HIV, are presented in Table 14. Comparing HIVST as the least costly 
service delivery model to a scenario where no community-based service delivery model is 
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implemented, we see that the costs per man tested and per man newly diagnosed with HIV under 
HIVST are $5.02 and $82.54, respectively.  
To realize gains in the number of men who test for HIV, decision makers could 
implement HBT or CHC instead of HIVST. If decision makers are willing to spend at least $9.03 
yet less than $16.24 per man tested, then HBT is the preferred alternative and would result in an 
enhanced uptake of HIV testing by 780,935 additional men. If decision makers are willing to 
spend $16.24 or more per man who tests for HIV, CHC is the preferred alternative and would 
result in an enhanced uptake of HIV testing by 1,665,996 additional men.  
To realize gains in the number of men newly diagnosed with HIV, decision makers could 
implement CHC instead of HIVST. The ICER reveals that the incremental cost per additional 
man newly diagnosed with HIV under CHC is $1,790. If decision makers are willing to spend at 
least that much per new HIV diagnosis, CHC is the preferred alternative for increasing HIV 
diagnosis among men and would result in 11,967 additional diagnoses. If decision makers are not 
willing to spend that much yet are willing to spend at least $83 per new HIV diagnosis, HIVST is 
the most cost-effective alternative for increasing HIV diagnosis among men.  
Deterministic Sensitivity Analyses 
Shifting the base case values for uncertain and volatile parameters in our decision 
analytic model revealed that our results are sensitive to certain changes on the HIV testing 
landscape (Tables 15 and 16). One important parameter dictating the cost-effectiveness of 
alternative community-based service delivery models to increase HIV diagnosis is the 
probability that men who use HIVST will test positive. Shifting this parameter input 3 
percentage points below the base case value which was estimated using the current adult male 
HIV prevalence makes it considerably more likely that HBT and CHC will be preferred 
alternatives for increasing HIV diagnosis. On the other hand, if this parameter input is shifted 3 
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percentage points above the base case value, HIVST dominates both HBT and CHC as the most 
cost-effective alternative to increase HIV diagnosis. Changes to other model parameters had less 
pronounced impacts.  
If previously diagnosed HIV-positive are found to use HIVST to confirm their HIV 
status, it becomes less likely that HIVST is cost-effective and more likely that CHC is cost-
effective at increasing HIV diagnosis among men. If the cost of HIVST is doubled, it becomes 
more likely that HBT is cost-effective at increasing HIV testing yet HBT remains weakly 
dominated by HIVST as an alternative for increasing HIV diagnosis. If uptake under HBT is 
increased to 69% of the adult male population, HBT dominates CHC as an alternative for 
increasing HIV testing and becomes a contender as a cost-effective alternative for increasing 
HIV diagnosis. However, if non-disclosure of prior HIV diagnoses before HBT is a reality, HBT 
remains dominated by HIVST as an alternative for increasing HIV diagnosis.5 Providing 
immediate access to ART for HIV-positive persons and offering US $0.85 incentives to 
encourage men to test for HIV under CHC have little effect on the likelihood that CHC is a cost-
effective alternative for increasing HIV testing yet do increase the likelihood that CHC is a cost-
effective alternative for increasing HIV diagnosis. 
Probabilistic Sensitivity Analysis 
Compared to our base case results, the range of WTP thresholds over which HIVST was 
most likely to be cost-effective at increasing the number of men tested for HIV was narrower 
when probabilistic sensitivity analysis was performed (Figure 10). We found that HIVST is the 
                                                 
5We present the result of a one-way sensitivity analysis for non-disclosure of prior HIV diagnosis in Table 4. Yet, if 
we were to conduct a two-way sensitivity analysis to investigate higher uptake of HIV testing under HBT that 
occurred concurrently with non-disclosure of prior HIV diagnosis, we find that non-disclosure by just 2% of men 
rendered HBT a dominated strategy for increasing HIV diagnosis. 
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alternative most likely to be cost-effective in terms of total numbers of men tested when decision 
makers are willing to pay US $5.12 - $7.03 per man who tests for HIV. HBT was the alternative 
most likely to be cost-effective when decision makers are willing to pay US $7.04 – $17.58 per 
man tested for HIV, and CHC was most likely to be cost-effective when decision makers are 
willing to spend $17.59 or more per man tested for HIV.  
Probabilistic sensitivity analysis confirmed that HIVST and CHC are the only 
alternatives that are most likely to be cost-effective at increasing HIV diagnosis (Figure 11). We 
found that HIVST was the alternative most likely to be cost-effective in terms of total new HIV 
diagnoses when decision makers are willing to spend US $86 - $1,144 per new HIV diagnosis. 
CHC was most likely to be cost-effective when decision makers are willing to spend more than 
$1,144 per new diagnosis.  
4.5. Discussion 
Our decision analytic model revealed that community-based service delivery models for 
HIV testing vary in their effectiveness and costs to increase HIV testing and HIV diagnosis 
among men in Uganda. CHC is predicted to yield the greatest number of men who test for HIV 
and who are newly diagnosed with HIV and is therefore the preferred alternative if WTP 
thresholds are not constrained. Yet, CHC requires substantially higher costs to implement than 
the other two service delivery models, and HIVST and HBT are more cost-effective alternatives 
for increasing male testing at WTP thresholds less than $17.59 per man tested for HIV. If the 
outcome of interest is new HIV diagnoses, HIVST alone is more cost-effective than CHC at 
WTP thresholds less than $1,144 per new diagnosis. This latter finding is significant because 
attainment of the first 90-90-90 target hinges on increasing HIV diagnosis among individuals 
previously unaware of their HIV status. Although many efforts to attain this target have focused 
on expanding testing coverage, we demonstrate that service delivery models that are cost-
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effective alternatives for increasing HIV testing are not necessarily cost-effective alternatives for 
increasing HIV diagnosis. This important result has not been highlighted in previous studies. 
One prior cost-effectiveness analysis found that HBT is cost-effective relative to facility-based 
testing at increasing HIV testing and HIV diagnosis (98). This analysis assumed similar uptake 
of HIV testing under HBT and facility-based testing which is unlikely is practice. Additionally, 
that study and others have concluded that the costs of community-based service delivery models 
to deliver HIV testing are relatively low and comparable (36,97,98). We demonstrate, however, 
that seemingly small differences in the costs to deliver HIV testing can translate into 
considerable differences in costs to achieve the immediate secondary outcome of HIV diagnosis. 
We consider it important to highlight these differences in light of the context where constraints 
on spending for health are considerable.     
Given the focus on increasing awareness among HIV-positive persons, it could be 
questioned whether decision makers should take interest in the cost-effectiveness of alternative 
community-based service delivery models to increase HIV testing at all or whether the outcome 
of interest should simply be new HIV diagnoses. We included HIV testing uptake as an outcome 
because HIV testing does hold health benefits for testers regardless of testing outcome. For 
instance, HIV testing leads to safer sexual decision making. A systematic review indicates that 
individuals who learn that they are HIV positive following HIV testing have fewer sexual 
partners and increased condom use than individuals who test HIV-negative (10). Depending on 
the service delivery model, HIV testing can also provide important prevention benefits for HIV-
negative men such as linkage to voluntary medical male circumcision and pre-exposure 
prophylaxis for those at high risk of acquiring HIV (17,113). These prevention benefits were 
outside the scope of our analysis, yet we present findings regarding the cost-effectiveness of 
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alternative service delivery models to increase HIV testing for decision-makers to consider and 
as a stepping-stone for further analyses.  
We also found that our results are quite sensitive to changes in certain parameter inputs. 
The probability that men who use HIVST will test HIV-positive, in particular, has a strong 
impact on our results. We assumed a base case value based on the current male HIV prevalence, 
yet it is possible that a novel service delivery model such as HIVST could appeal more or less 
strongly to HIV-positive men. If undiagnosed HIV-positive men are more likely to use HIVST, 
HIVST has the potential to quickly dominate the other service delivery models as an alternative 
to increase HIV diagnosis. We altered the probability of a positive test result only for HIVST as 
a novel service delivery model that has demonstrated potential to appeal to hard-to-reach and 
high-risk populations in other settings (43,55,114,115). However, we note that altering this 
parameter input for any of the service delivery models would have a similar impact. To the 
extent that any of the service delivery models can be modified to encourage undiagnosed HIV-
positive men to test for HIV, the likelihood that the service delivery model will be cost-effective 
at increasing new diagnoses of HIV rapidly increases, even if the initial uptake of HIV testing 
remains unchanged.  
We acknowledge three limitations of our analysis. First, our use of stated preference data 
collected for a DCE to predict uptake under each of the service delivery models is innovative and 
advances a methodological frontier for the use of DCEs to furnish uptake estimates in the 
absence of observed uptake estimates (i.e. revealed preference data). Yet, choices made in a DCE 
might not be entirely consistent with choices made in reality. A recent systematic review and 
meta-analysis indicates that stated choices do reasonably predicted revealed choices (25), yet 
additional evidence to confirm the concordance between stated and revealed preferences is 
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urgently needed. Second, we evaluated outcomes when a single community-based service 
delivery model for HIV testing is made available in rural Uganda and assumed no other 
community-based service delivery models for HIV were available at the same time. Yet, such a 
scenario does not exclude the possibility that HIV testing is also available at health facilities, and 
we were not able to account for substitution behaviors to know whether men who test for HIV 
via a community-based service delivery model would have tested at a health facility if a 
community-based service delivery model for HIV testing was not available. Third, our decision 
analytic model allows us to evaluate the cost-effectiveness of community-based service delivery 
models to promote two important HIV testing outcomes, yet we do not consider other health 
benefits that could result from accessing a community-based service delivery model for HIV 
testing aside from these testing outcomes. Nor do we consider downstream health outcomes that 
are of critical importance for HIV-positive men and for HIV prevention. For instance, we do not 
evaluate linkage to antiretroviral treatment following an HIV-positive test result, which could 
vary by service delivery model, or long-term retention in care and viral suppression. Modeling 
these downstream outcomes could lead to an outcome such as disability-adjusted life years or 
HIV infections averted for which WTP thresholds are more established. Our data are instead 
most relevant for the community-based testing environment, and we encourage further research 
to strengthen the evidence base regarding individual health behaviors and engagement with care 
following HIV testing under community-based service delivery models.  
Despite these limitations, our study delivers timely and important findings for decision 
makers who seek to allocate resources to increase HIV testing and HIV diagnosis among men. 
We reveal that HIVST is most likely to be cost-effective at increasing HIV testing by men over a 
range of WTP thresholds of US $5.12 - $7.03 per man who tests for HIV; HBT is most likely to 
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be cost-effective at increasing HIV testing by men for WTP thresholds of US $7.04 – $17.58 per 
man who tests for HIV, and CHC is most likely to be cost-effective at increasing HIV testing by 
men for WTP thresholds greater than US $17.58. We further show that the alternatives that are 
most cost-effective at increasing HIV testing are not necessarily the most cost-effective 
alternatives at increasing HIV diagnosis. We found that HIVST is most likely to be cost-effective 
at increasing HIV diagnosis among men over a range of WTP thresholds of US $86 - $1,144 per 
new HIV diagnosis; for WTP thresholds greater than US $1,144 per new diagnosis, CHC was 
most likely to be cost-effective at increasing HIV diagnosis among men. As testing coverage 
expands, it is likely that attainment of the first 90-90-90 target will increasingly depend on 
service delivery models that do not simply increase uptake of HIV testing by men but increase 
uptake by HIV-positive men who are unaware of their status, and our work suggests that 
increasing the effectiveness of community-based service delivery models to target undiagnosed 
HIV-positive men is likely to have a major impact on the cost-effectiveness landscape. Finally, 
our work identifies priorities for further investigation. We employed innovative methods to 
predict uptake of HIV testing under existing and novel service delivery models for HIV testing, 
and further research is warranted to assess the concordance between uptake predictions derived 
from stated preference research and uptake that is observed under real-world implementation. 
We also encourage research to evaluate the subsequent health behaviors and health outcomes of 
individuals who test for HIV and who are diagnosed with HIV under community-based service 
delivery models.  
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Figure 7. Decision Tree Comparing Uptake of HIV Testing and New HIV Diagnoses under 










Adult (≥18 years) male population of 
rural Uganda 
5,206,236 Uganda Bureau of Statistics 
Probability of HIV testing (i.e. 
uptake)  
  
  HIVST 0.32 DCE 
  HBT 0.47 DCE 
  CHC 0.64 DCE 
Probability of testing HIV-positive   
  HIVSTa 0.061 
Assumption; Uganda AIDS Indicator 
Survey, 2011; FDA Center for Biologics 
Evaluation and Research, 2018 
  HBTb 0.031 
Asiimwe et al., 2017; Tumwesigye et 
al., 2011 
  CHCb 0.068 Chamie et al., 2018; Chamie et al. 2012 
Probability of new HIV diagnosis 
 
  
  HIVST 1.00 Assumption  
  HBT 1.00 Asiimwe et al., 2017 
  CHC 0.50 Chamie et al., 2018; Chamie et al., 2012 
Per-person cost to deliver HIV testing 
(2016 USD)  
  
  HIVST $5.02 Micro-costed 
  HBT $6.30 
Asiimwe et al., 2017; Tumwesigye et 
al., 2011; Menzies et al., 2009; Mulogo 
et al., 2013 
  CHC $8.94 Chang et al., 2016; Chamie et al., 2012 
a The probability of testing HIV-positive was estimated using the prevalence of HIV among 
testers and the sensitivity and specificity of OraQuick HIV self-tests. We assumed that the 
HIV prevalence among testers who use HIVST is 6.6%, the same as the adult male prevalence 
for the region.  We further adjusted this estimate for false positive results using the positive 
predictive value of OraQuick HIV self-tests.  
b HBT and CHC employ testing algorithms whereby a confirmatory test is administered 
following a reactive first test. A tie-breaker test is administered in cases of inconsistent test 
results. The positive predictive value for HIV testing under these service delivery models is 
therefore 1.00, and these estimates of the probability that men will test positive under HBT and 
CHC are pulled directly from the literature. 
 
 
Table 14. Base Case Results of the Costs and Effectiveness of Different Service Delivery Models to Increase HIV Testing and 
Diagnosis 
Service delivery model 
Total cost 
(US $) 
Number of men 
tested for HIV 
Number of new 
HIV diagnoses 
ICER  (US $ 
/Additional man 
tested) 




service delivery model 
$0 0 0 -- -- 
HIVST $8,363,298 1,665,996 101,321 $5.02 $83 
HBT $15,415,665 2,446,931 75,855 $9.03 Dominated  
CHC $29,788,000 3,331,991 113,288 $16.24a $1,790b 
ICERs are calculated with respect to the next least costly service delivery model. In cases where a service delivery model is more 
costly yet less effective, it is eliminated from consideration as a dominated alternative and remaining ICERs are calculated 
excluding the dominated alternative. US $, United States dollars; ICER, incremental cost-effectiveness ratio; HIVST, HIV self-
testing using an oral fluid-based test obtained at a local pharmacy; HBT, counselor-administered home-based testing; CHC, HIV 
testing at a community health campaign. 
a This ICER was calculated with respect to HBT. If we calculated the incremental costs and effectiveness with respect to HIVST, the 
ICER would be $12.64 / additional man tested.  







Figure 8. Efficiency Frontier for Community-Based Service Delivery Models to Increase HIV 
Testing 
 
Figure 9. Efficiency Frontier for Community-Based Service Delivery Models to Increase HIV 
Diagnosis 
 
The total number of men tested for HIV and the number of men newly diagnosed with HIV and are plotted 
alongside the total costs to implement each service delivery model on the efficiency frontiers. The inverse of the 
slope of the lines connecting the points provide the incremental cost-effectiveness ratios for one service delivery 
model relative to another. Points that fall below the lines connecting the points represent dominated alternatives. 
HIVST, HIV self-testing using an oral fluid-based test obtained at a local pharmacy; HBT, counselor-administered 
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CHC possibly cost-effective 
US $, United States dollars; ICER, incremental cost-effectiveness ratio; HIVST, HIV self-testing using an oral fluid-based test 
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Figure 10. Cost-Effectiveness Acceptability Curves Representing the Probability that Alternative Community-Based Service Delivery 




























































Cost willing to pay per man who tests for HIV (US $) 








Figure 11. Cost-Effectiveness Acceptability Curves Representing the Probability that Alternative Community-Based Service Delivery 



























































Cost willing to pay per man who is newly diagnosed with HIV (US $) 














CHAPTER 5.  SUMMARY, IMPLICATIONS, AND CONCLUSIONS 
 This dissertation advances knowledge regarding men’s stated preferences for attributes of 
community-based HIV testing in Uganda and is significant because it delivers findings to help 
address the current gap in male testing coverage in sub-Saharan Africa. The three research 
papers included in this dissertation respond to questions that are important for policymakers and 
practitioners to consider when determining how to improve the delivery of community-based 
HIV testing to promote male testing, and the overall goal of this dissertation was to provide a 
comprehensive evaluation of the potential of different service delivery models and interventions 
to promote HIV testing by men. To conclude, I discuss the implications of this dissertation for 
policy, practice, and future research. I begin by summarizing the key findings and limitations of 
each research paper.   
5.1. Summary of Findings 
 In the first research paper, I presented the results of a discrete choice experiment (DCE) 
designed to: 1) elicit stated preferences for policy-relevant attributes of HIV testing that can be 
modified to encourage men to test for HIV, and 2) predict uptake of HIV testing under 
alternative community-based service delivery models (HIV testing at a community health 
campaign, counselor-administered home-based testing, and HIV self-testing using an oral fluid-
based self-test obtained at a local pharmacy). The DCE was administered to a representative 
sample of 203 adult male residents of rural Uganda. I found that the most important attribute to 
participants was the provision of immediate access to ART for HIV-positive persons which 
increased the predicted uptake of HIV testing under the alternative community-based service 
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delivery models by 26-44 percentage points.  The provision of US $0.85 incentive also 
influenced participants’ choices and increased the predicted uptake of HIV testing under the 
alternative community-based service delivery models by 6-12 percentage points. Participants’ 
stated preferences suggested that they would much rather test for HIV using the community-
based service delivery models presented in the DCE than opt-out of HIV testing, and an 
important methodological advance made in this paper was the calibration of uptake predictions 
to match observed estimates of testing uptake reported in peer-reviewed literature (i.e. revealed 
preference data).  
 The focus of the second research paper was heterogeneity in men’s stated preferences for 
attributes of HIV testing. I estimated and compared goodness-of-fit measures for conditional, 
random parameters, and latent class logit model specifications, each of which makes different 
assumptions about the distribution of preferences in a sample. I also conducted covariate 
analyses to assess whether preference heterogeneity can be attributed to observed characteristics 
of participants. Estimation of preferences using random parameters and latent class logit model 
specifications considerably improved model fit relative to the conditional logit model 
specification. Both the random parameters and latent class logit model specifications account for 
preference heterogeneity, and I concluded that men’s preferences for attributes of HIV testing are 
heterogenous. The covariate analyses suggested differences in participants’ utility for opting out 
of HIV testing yet did not reveal differences in preferences for policy-relevant attributes of HIV 
testing that could be modified to encourage men to test for HIV. It is likely that the DCE was 
underpowered to detect differences in preferences for attributes of HIV testing associated with 
observed characteristics of men, and a key limitation of this paper is that it cannot be resolved 
whether preference heterogeneity can be attributed to observed characteristics of men.  
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 The third research paper presented the results of a cost-effectiveness analysis comparing 
three community-based service delivery models to promote HIV testing and diagnosis among 
adult men in rural Uganda. I compared HIV testing at multi-disease community health 
campaigns, counselor-administered home-based testing, and the distribution of oral fluid-based 
HIV self-tests at local pharmacies relative to a status quo scenario where no community-based 
service delivery model for HIV testing is available. I incorporated uptake predictions from the 
DCE into the cost-effectiveness analysis to estimate the likelihood that adult men will test for 
HIV under each service delivery model. Doing so made it possible to investigate a novel service 
delivery model (i.e. the HIV self-test service delivery model) for which no estimates of observed 
uptake are available. An important conclusion was that service delivery models that are most 
cost-effective at increasing HIV testing by men are not necessarily the most cost-effective at 
increasing HIV diagnosis among men. Additionally, the results regarding the cost-effectiveness 
of the service delivery models to increase HIV diagnosis were highly sensitive to changes in the 
prevalence of HIV among men who test under each service delivery model. The likelihood that a 
service delivery model was the most cost-effective alternative increased dramatically when the 
prevalence of HIV among testers increased by only a few percentage points.  
5.2.  Implications for Policy and Practice 
 The findings from this dissertation research hold several implications for policy and 
practice. It is instructive that men stated strong preferences for the immediate provision of ART 
when accessing community-based HIV testing. Ensuring access to ART for HIV-positive 
persons via community-based service delivery models requires a number of enhanced 
operational capacities. First, personnel who can counsel individuals who test HIV-positive on the 
use of ART are required. Second, it would be beneficial for disease staging (e.g. point-of-care 
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CD4 testing) to be provided following HIV diagnosis. Third, it is essential that HIV-positive 
persons are linked to health systems for long-term treatment and care.  
 It is also instructive that US$ 0.85 incentives led to a predicted increase in uptake of HIV 
testing by men. The resource requirements to provide incentives are less intensive than those 
required to administer ART via community-based service delivery models for HIV testing and 
the feasibility of implementing incentivized interventions for community-based HIV testing has 
been demonstrated (20,40). Yet, offering incentives for HIV testing raises a number of social 
implications. For instance, whether incentives are offered only to men or also to women is a 
matter for consideration. Aside from the gap in male testing coverage, this dissertation does not 
focus on other inequalities between men and women, many of which disfavor women. The 
preference-based approach I assumed for this dissertation reveals attributes of HIV testing that 
appeal and can be leveraged to increase testing uptake by men, and it is important for decision 
makers to ensure that potentially effective policies and interventions are implemented in a 
manner that is consistent with broader policy objectives. 
 Decision makers should also be aware that men’s preferences are heterogeneous. 
Although it could not be concluded that preferences vary for certain policy-relevant or 
demographic subgroups of men, decision makers should keep in mind that preference 
heterogeneity is an area for further investigation and several approaches might be warranted to 
achieve the greatest uptake of HIV testing.   
 Lastly, the cost-effectiveness analysis revealed that the landscape of community-based 
HIV testing is sensitive to a number of changes and particularly to changes in the effectiveness 
of different service delivery models to induce uptake of HIV testing by undiagnosed HIV-
positive men. Implementers of community-based service delivery models should seek to uncover 
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ways to enhance the effectiveness of community-based service delivery models to increase HIV 
testing by undiagnosed HIV-positive men.  
5.3.  Next Steps and Future Research 
 The findings and limitations of my research papers spur further investigation. First, 
findings from the first paper indicated that providing immediate access to ART and offering US 
$0.85 incentives are likely to increase HIV testing by men, and research is warranted to assess 
the feasibility and confirm the effectiveness of these interventions. More generally, research to 
corroborate the external validity of stated preferences to predict revealed preferences is merited 
and would advance the field of stated preference research.   
Second, my investigation of preference heterogeneity could not resolve whether 
heterogeneity was associated with observed characteristics of men and further research is needed 
to determine whether certain service delivery models and interventions can be leveraged to 
promote testing by priority subpopulations of men.  
Third, results from the cost-effectiveness analysis of alternative service delivery models 
to increase HIV diagnosis among men indicated that providing immediate access to ART for 
HIV-positive persons and offering US $0.85 incentives at multi-disease community health 
campaigns would increase the likelihood that a community health campaign is cost-effective. 
Another type of economic evaluation that would be beneficial for decision makers to understand 
the financial implications of implementing these interventions is a budget impact analysis (116).  
Fourth, my dissertation research focused on increasing knowledge of community-based service 
delivery models and interventions that can be harnessed to increase HIV testing by men yet 
subsequent health outcomes are of critical importance. Further research is needed to investigate 
linkage to care following community-based HIV testing and to evaluate health outcomes of HIV-




Community-based service delivery models for HIV testing hold considerable potential 
and can be strengthened to promote HIV testing by men in sub-Saharan Africa. I found that 
modifying attributes of how testing is delivered is likely to have relatively modest to quite 
profound impacts on uptake of HIV testing by men in rural Uganda. I further found that the cost-
effectiveness of alternative community-based service delivery models to increase HIV diagnosis 
among men hinges on the effectiveness of service delivery models to induce uptake by 
undiagnosed HIV-positive men. This dissertation provides evidence to strengthen the delivery of 
community-based HIV testing to promote HIV testing by men in sub-Saharan Africa and 
motivates future research of strategies to effectively promote HIV testing among undiagnosed 
HIV-positive men.  
 
 
APPENDIX A. ATTRIBUTE LEVELS THAT WERE PAIRED AND THAT WERE CONSTRAINED FROM PAIRING 








HIVST using an oral fluid-based 











Multi-disease testing is provided Multi-disease testing is provided Multi-disease testing is provided 
Multi-disease testing is not provided Multi-disease testing is not provided Multi-disease testing is not provided 
ART is immediately available  
for HIV-positive persons 
ART is immediately available  
for HIV-positive persons 
ART is immediately available  
for HIV-positive persons 
ART is not immediately available  
for HIV-positive persons 
ART is not immediately available  
for HIV-positive persons 
ART is not immediately available  
for HIV-positive persons 
An incentive of US $0.85 is provided An incentive of US $0.85 is provided An incentive of US $0.85 is provided 
An incentive of US $0.85  
is not provided 
An incentive of US $0.85  
is not provided 
An incentive of US $0.85  
is not provided 
The hatched cells represent attribute levels that were constrained from pairing with a specific service delivery model. HIVST, HIV 






APPENDIX B. CALIBRATION OF PREDICTED UPTAKE OF HIV TESTING 
USING REVEALED PREFERENCE DATA REPORTED IN PEER-REVIEWED 
LITERATURE 
Using a discrete choice experiment (DCE) to generate uptake predictions allows us to 
evaluate the likelihood that men will access different service delivery models to test for HIV 
when they are made available in rural communities. Yet, one limitation of our approach is that 
hypothetical choices may not mirror real world choices. To account for this possibility and to 
strengthen confidence in our uptake predictions, we implemented a calibration procedure to 
ensure that uptake predictions generated from the DCE matched reference values of testing 
uptake that have been reported in peer-reviewed literature (i.e. revealed preference data).  
Kenneth Train outlines the calibration procedure we implemented. In Discrete Choice 
Methods with Simulation (2009), Train advises adjusting the alternative-specific constants 
included in the discrete choice model in order to forecast market shares (64). An alternative-
specific constant captures the average effect on utility for the alternative of all factors that are not 
included in the model. An alternative-specific constant is thus analogous to a constant (i.e. an 
intercept) in other regression frameworks. The rationale underlying calibration is that unobserved 
factors might differ in the forecast environment from unobserved factors in the experimental 
environment constructed in a DCE. For our context, it is likely that unobserved factors in a real-
world environment (i.e. the forecast environment) differ from unobserved factors that influenced 
men’s choices in the discrete choice experiment. 
To account for these differences, Train recommends adjusting the alternative specific 
constants in an iterative manner using the following formula:  
hN
b =  hN





i is the alternative-specific constant estimated by the discrete choice model. _N is the 
share of decision makers who choose alternative P in the forecast environment and _N
i is the share 
of decision makers who are predicted to choose alternative P using the results of the discrete 
choice experiment. Using this formula, we compare the share of decision makers who have 
actually been observed to choose alternative P in practice relative to the share of individuals that 
we predict will choose alternative P using DCE-derived preference estimates. If the observed 
share of decision makers who choose alternative P is greater than the predicted share, we raise the 
constant. If the observed share of decision makers who choose alternative P is less than the 
predicted share, we lower the constant. The new constant we obtain is hN
b. We then use hN
b to 
generate uptake predictions and again, compare the predicted share of decision makers who 
choose alternative P to the observed share of decision makers who chose alternative P in practice. 
In this manner, we iteratively adjust the alternative-specific constant until the predicted share of 
decision makers who choose alternative P matches the observed share of decision makers who 
chose alternative P in practice.  We then make all other relevant predictions using the adjusted 
alternative-specific constant.  
For our analysis, we estimated preferences using a single alternative-specific constant for 
the alternative to opt-out of HIV testing.1 We then made predictions for two choice scenarios. In 
the first scenario, we predicted uptake of HIV testing by adult men when a single community-
based service delivery model for HIV testing is implemented. In the second scenario, we 
predicted uptake of HIV testing when two community-based service delivery models for HIV 
                                                 
1The alternative to opt-out of HIV testing was the only alternative that was the same across all choice sets, and the 
testing alternatives that participants viewed in the choice sets were unlabeled. The use of a single alternative-specific 
constant is therefore appropriate. 
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testing are implemented concurrently. To establish calibration reference values, we therefore 
needed to identify observed estimates of testing uptake (or, more specifically, testing decline) 
when community-based service delivery models for HIV testing have been implemented in the 
study context and adult men have been presented with comparable choice scenarios.  
Following a review of relevant peer-reviewed studies, we selected a single study that 
provided reference values for both choice scenarios. In “A hybrid mobile approach for 
population-wide HIV testing in rural east Africa: an observational study”, Chamie et al. (2016) 
report uptake of HIV testing by adult residents of 32 communities in Uganda and Kenya under a 
hybrid mobile strategy to promote HIV testing (68). Prior to the hybrid mobile testing strategy, a 
door-to-door census was conducted in each study community. Residents were invited to attend a 
community health campaign that was held in their community. Multi-disease testing was 
provided at the community health campaign but a US $0.85 incentive and immediate access to 
ART for HIV-positive persons were not. Adult residents who did not attend the community 
health campaign were traced and offered home-based testing. Under the hybrid mobile testing 
strategy, it was estimated that 64% of adult male residents tested for HIV at the community 
health campaign. An additional 12% tested for HIV by way of home-based testing for a total 
observed uptake of HIV testing by 86% of adult male residents. It can equally be observed that 
36% of adult male residents opted-out of testing for HIV at the community health campaign and 
that 14% of adult male residents opted-out of HIV testing when it was possible to test either at a 
community health campaign or by way of home-based testing. We used these observed estimates 
of testing decline as reference values for calibration. We then applied Train’s adjustment for the 
alternative-specific constant.  
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Given that we generated uptake predictions using individual preference estimates, we 
applied the adjustment on the individual level as well. That is, we adjusted the alternative-
specific constant simulated for each individual in the sample, predicted whether each individual 
in the sample would test for HIV for a given choice scenario, summed the individual predictions 
to obtain the aggregate predicted uptake for the sample, compared the aggregate predicted uptake 
to the observed predicted uptake reported by Chamie et al. (2016), and adjusted the individual 
alternative-specific constants iteratively until the aggregate predicted uptake matched the 
observed predicted uptake.  
In Figures B1 and B2, we compare our predictions of testing uptake before and after 
calibration when a single community-based service delivery model is implemented in Uganda. 
What is starkly evident is that calibration has an important effect when making predictions of 
testing uptake for this choice scenario. Without calibration, we predict very high rates of testing 
uptake across all service delivery models. We know from observed estimates of testing uptake 
reported in peer-reviewed literature that our predictions are not accurate. Following calibration, 
we obtain predictions of testing uptake that are consistent with a reference value of 64% of adult 
men who test for HIV at a multi-disease community health campaign. We have far greater 
confidence in our predictions following calibration. In Figures B3 and B4, we compare our 
predictions of testing uptake before and after calibration when two community-based service 
delivery models are implemented concurrently. The differences in uptake before and after 
calibration are less pronounced for this second choice scenario, yet it can still be observed that 
calibration adjusts uptake predictions downward to match an 86% reference value of testing 
uptake by adult men whether both HIV testing at a multi-disease community health campaign 
and counselor-administered home-based testing are available as service delivery models for HIV 
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testing. It makes sense that the differences in predicted verses observed estimates of testing 
uptake are less stark as this second choice scenario is consistent with the format of the choice 
sets that participants viewed in the DCE.  
 
 
Figure B1. Predicted Uptake of HIV Testing under a Single Service Delivery Model before 
Calibration 
 





Figure B2. Predicted Uptake of HIV Testing under a Single Service Delivery Model after 
Calibration 
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Figure B3. Predicted Uptake of HIV Testing when Two Service Delivery Models are 
Implemented in Tandem before Calibration 
 




Figure B4. Predicted Uptake of HIV Testing when Two Service Delivery Models are 
Implemented in Tandem after Calibration 
  
 





APPENDIX C. COST CATEGORIES FOR DISTRIBUTION OF HIV SELF-TESTS 




(2017 US $) 
Percentage 
of total cost 
Mobilization (radio and SMS broadcast announcements and 
pharmacy posters) 
6,545 6% 
HIV self-test procurement (purchase of self-tests, freight, 
import duties, and 18% VAT) 
89,220 80% 
Delivery of self-tests to retailers (local truck hire with fuel, 3 
days/quarter) 
480 <1% 
Communication with retailers (airtime) 222 <1% 
Personnel 13,200 12% 
Building & overhead 1,320 1% 





APPENDIX D. ADDITIONAL COSTS FOR PROVIDING ART AND FINANCIAL 
INCENTIVES AT COMMUNITY HEALTH CAMPAIGNS  
Table D1. Additional costs for providing immediate access to ART for HIV-positive persons at 




(2017 US $) 
Percentage 
of total cost 
Point of care CD4 testing 46,516 48% 
Drugs - 2 week supply of antiretrovirals 15,820 16% 
Linkage support (shuttle service and travel vouchers) 6,252 6% 
Personnel 26,400 27% 
Building & overhead 2,640 3% 
Total estimated cost to provide ART on site for newly 
diagnosed HIV-positive persons:  
97,628   
 
 





(2017 US $) 
Percentage 
of total cost 
3,000 UGX incentives and transaction fees 41,342 74% 
Storage and safety 117 <1% 
Personnel 13,200 24% 
Building & overhead 1,320 2% 
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